JPH0665237A - Substituted pyrazole derivative and germicide for agriculture and horticulture - Google Patents

Substituted pyrazole derivative and germicide for agriculture and horticulture

Info

Publication number
JPH0665237A
JPH0665237A JP9806093A JP9806093A JPH0665237A JP H0665237 A JPH0665237 A JP H0665237A JP 9806093 A JP9806093 A JP 9806093A JP 9806093 A JP9806093 A JP 9806093A JP H0665237 A JPH0665237 A JP H0665237A
Authority
JP
Japan
Prior art keywords
group
substituted
unsubstituted
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP9806093A
Other languages
Japanese (ja)
Inventor
Yasuyuki Nakajima
康之 中島
Junichi Watanabe
淳一 渡辺
Yasuhisa Sugiyama
泰久 杉山
Yoji Hirohara
洋司 廣原
Takeshi Mita
猛志 三田
Hideo Suzuki
秀雄 鈴木
Takashi Furusato
孝 古里
Hiroshi Oya
博司 大宅
Masahito Nakayama
雅人 中山
Masami Hanaue
雅美 花上
Ryutaro Toyoda
竜太郎 豊田
Tadashi Ito
忠 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP9806093A priority Critical patent/JPH0665237A/en
Publication of JPH0665237A publication Critical patent/JPH0665237A/en
Pending legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PURPOSE:To provide a novel compound useful as a germicide for agriculture and horticulture. CONSTITUTION:A compound of formula I [R<1> is halogen, (halo)alkyl, alkoxy, alkylthio; R<2> is (halo)alkyl; X is -N(R<3>)-, -CO-, -C(R<4>)(R<5>)-; Y is -O-,-S(O)-; (n) is 0-2; R<3> is H, alkanoyl, etc.; R<4>, R<5> are H, halogen, alkoxy, etc.; A is (substituted)phenyl; B is (substituted)heterocyclic group], e.g. 2-pyridyl-(4-(4- chlorophenylthio)-1,3-dimethyl-5-pyrazolyl)methanol. The compound of formula I is obtained by reacting a substituted pyrazole of formula II (X is -N(R<3>)-) with a heterocyclic compound of formula: L-B (L is a releasing group such as halogen), if necessary, in the presence of a base in a solvent. The compound of formula I is useful for plant diseases such as gray mold, rice sheath blight, melon downy mildew, and the melanose, powdery mildew, bitter rot and epidemic of citruses.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、新規なピラゾール誘導
体および該誘導体を有効成分として含有する農園芸用殺
菌剤に関する。
TECHNICAL FIELD The present invention relates to a novel pyrazole derivative and an agricultural / horticultural fungicide containing the derivative as an active ingredient.

【0002】[0002]

【従来の技術】これまで種々の殺菌剤が開発されてきて
いるが、その効力や耐性菌の出現等で必ずしも満足すべ
きものとは言えない。また特開平 1-125379 号公報、EP
-459333A1 、特開平3-141276号公報には、ある種のピラ
ゾール誘導体が殺菌活性を有することが記載されてい
る。
2. Description of the Related Art Various bactericides have been developed so far, but they are not always satisfactory because of their efficacy and appearance of resistant bacteria. Also, JP-A 1-125379, EP
-459333A1 and JP-A-3-141276 describe that certain pyrazole derivatives have bactericidal activity.

【0003】[0003]

【発明が解決しようとする課題】上記の公開公報に記載
されている化合物においても、効力、残効性、薬害等の
点で満足すべきものではなく、植物病害に対して更に有
用な農園芸用殺菌剤の開発が要望されている。
The compounds described in the above publications are not satisfactory in terms of potency, residual efficacy, phytotoxicity, etc., and are more useful for plant and garden diseases. Development of a bactericide is desired.

【0004】[0004]

【課題を解決するための手段】本発明者らは、このよう
な状況に鑑み、優れた殺菌活性を有する化合物を開発す
べく種々検討を重ねた結果、下記式〔1〕で示される置
換ピラゾール誘導体が、優れた殺菌活性を有することを
見出し本発明に至った。すなわち、本発明は、式
〔1〕:
In view of the above situation, the present inventors have conducted various studies to develop a compound having excellent bactericidal activity, and as a result, have the substituted pyrazoles represented by the following formula [1]: The inventors have found that the derivative has excellent bactericidal activity, and have reached the present invention. That is, the present invention provides the formula [1]:

【0005】[0005]

【化2】 [Chemical 2]

【0006】〔上記式中、R1は、ハロゲン原子、アルキ
ル基、アルコキシ基、アルキルチオ基またはハロアルキ
ル基を表し、R2は、アルキル基またはハロアルキル基を
表し、Xは、-N(R3)- 、-CO-または-C(R4)(R5)- を表
し、R3は、水素原子、アルキル基、ハロアルキル基、ア
ルケニル基、アルキニル基、-COR6 または-SO2R7を表
し、R4およびR5は、それぞれ独立に水素原子、ハロゲン
原子、アルキル基、ハロアルキル基、アルケニル基、ア
ルキニル基または-OR8を表し、R8は、水素原子、アルキ
ル基、ハロアルキル基、アルケニル基、アルキニル基、
アルコキシアルキル基、シアノアルキル基、アルキルカ
ルボニルアルキル基、アルコキシカルボニルアルキル
基、無置換もしくは置換基を有するフェニルアルキル
基、-COR6 または-SO2R7を表し、R6は、水素原子、アル
キル基、ハロアルキル基、無置換もしくは置換基を有す
るフェニル基、無置換もしくは置換基を有するフェニル
アルキル基、アルコキシ基または-N(R9)(R10) を表し、
R7は、アルキル基、ハロアルキル基、無置換もしくは置
換基を有するフェニル基または-N(R9)(R10) を表し、R9
およびR10 は、それぞれ独立に水素原子、アルキル基ま
たは無置換もしくは置換基を有するフェニル基を表し、
Yは、酸素原子、-S- 、-SO-、または -SO2-を表し、A
は、無置換もしくは置換基を有するフェニル基を表し、
Bは、無置換もしくは置換基を有する複素環基を表す。
但し、R1が、アルキル基で、Xが、-N(R3)- で、Bが、
無置換の2−ピリジル基、無置換の2−ピリミジル基ま
たは無置換の2−ピラジル基の場合を除く。〕で表され
る置換ピラゾール誘導体またはその塩および該誘導体を
有効成分として含有する農園芸用殺菌剤に関するもので
ある。
[In the above formula, R 1 represents a halogen atom, an alkyl group, an alkoxy group, an alkylthio group or a haloalkyl group, R 2 represents an alkyl group or a haloalkyl group, and X represents —N (R 3 ). -, -CO- or -C (R 4) (R 5 ) - represents, R 3 represents a hydrogen atom, an alkyl group, a haloalkyl group, an alkenyl group, an alkynyl group, a -COR 6 or -SO 2 R 7 , R 4 and R 5 each independently represent a hydrogen atom, a halogen atom, an alkyl group, a haloalkyl group, an alkenyl group, an alkynyl group or —OR 8 , and R 8 is a hydrogen atom, an alkyl group, a haloalkyl group or an alkenyl group. , An alkynyl group,
Alkoxyalkyl group, cyanoalkyl group, alkylcarbonylalkyl group, alkoxycarbonylalkyl group, unsubstituted or substituted phenylalkyl group, -COR 6 or -SO 2 R 7 represents, R 6 is a hydrogen atom, an alkyl group Represents a haloalkyl group, an unsubstituted or substituted phenyl group, an unsubstituted or substituted phenylalkyl group, an alkoxy group or -N (R 9 ) (R 10 ),
R 7 represents an alkyl group, a haloalkyl group, an unsubstituted or substituted phenyl group or —N (R 9 ) (R 10 ), and R 9
And R 10 each independently represent a hydrogen atom, an alkyl group or an unsubstituted or substituted phenyl group,
Y represents an oxygen atom, -S-, -SO-, or -SO 2 - represents, A
Represents an unsubstituted or substituted phenyl group,
B represents an unsubstituted or substituted heterocyclic group.
Provided that R 1 is an alkyl group, X is —N (R 3 ) —, and B is
The case of an unsubstituted 2-pyridyl group, an unsubstituted 2-pyrimidyl group or an unsubstituted 2-pyrazyl group is excluded. ] It is related with the substituted pyrazole derivative represented by these, or its salt, and the agricultural and horticultural germicide containing this derivative as an active ingredient.

【0007】本発明において、上記式中の置換基は下記
の意味を有する。ハロゲン原子はフッ素、塩素、臭素お
よびヨウ素を意味し、好ましくはフッ素、塩素、臭素を
示す。アルキル基、アルコキシ基およびアルキルチオ基
のアルキルの炭素数は、それぞれ1〜6を意味し、例え
ばメチル、エチル、n−もしくはi−プロピル、n−,
s−,i−もしくはt−ブチル、ペンチル、ヘキシル、
メトキシ、エトキシ、n−もしくはi−プロポキシ、n
−,s−,i−もしくはt−ブトキシ、ペントキシ、ヘ
キソキシ、メチルチオ、エチルチオ、n−もしくはi−
プロピルチオ、n−,s−,i−もしくはt−ブチルチ
オが挙げられる。好ましくは、メチル、エチル、n−も
しくはi−プロピル、n−,s−,i−もしくはt−ブ
チル、メトキシ、エトキシ、n−もしくはi−プロポキ
シ、n−,s−,i−もしくはt−ブトキシが挙げられ
る。
In the present invention, the substituents in the above formula have the following meanings. The halogen atom means fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine and bromine. The number of carbon atoms of the alkyl of the alkyl group, the alkoxy group and the alkylthio group means 1 to 6, for example, methyl, ethyl, n- or i-propyl, n-,
s-, i- or t-butyl, pentyl, hexyl,
Methoxy, ethoxy, n- or i-propoxy, n
-, S-, i- or t-butoxy, pentoxy, hexoxy, methylthio, ethylthio, n- or i-
Examples include propylthio, n-, s-, i- or t-butylthio. Preferably, methyl, ethyl, n- or i-propyl, n-, s-, i- or t-butyl, methoxy, ethoxy, n- or i-propoxy, n-, s-, i- or t-butoxy. Is mentioned.

【0008】ハロアルキル基のアルキルの炭素数は1〜
6を意味し、例えばフルオロメチル、ジフルオロメチ
ル、トリフルオロメチル、クロロメチル、ブロモメチ
ル、トリフルオロエチル、トリクロロエチル、トリフル
オロプロピルなどが挙げられる。置換基を有するフェニ
ル基は、その置換基の数は1〜5であり、その置換基の
種類は、同じかまたは相異なってもよい。その置換基と
してハロゲン原子、アルキル基、ハロアルキル基、アル
コキシ基、アルキルチオ基、ニトロ基、シアノ基等で置
換されたフェニル基が挙げられる。但し、上記の定義中
のnはノルマルを、iはイソを、sはセカンダリーを、
tはターシャリーを表す。
The number of carbon atoms of the alkyl of the haloalkyl group is 1 to
6 means, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, bromomethyl, trifluoroethyl, trichloroethyl, trifluoropropyl and the like. The phenyl group having a substituent has 1 to 5 substituents, and the types of the substituents may be the same or different. Examples of the substituent include a phenyl group substituted with a halogen atom, an alkyl group, a haloalkyl group, an alkoxy group, an alkylthio group, a nitro group, a cyano group and the like. However, n in the above definition is normal, i is iso, s is secondary,
t represents tertiary.

【0009】上記のBで表される複素環とは、窒素原子
を1つ以上含有する5もしくは6員環複素環または窒素
原子を1つ以上含有する縮合複素環を表し、例えばピリ
ジン、ピリミジン、ピリダジン、ピラジン、トリアジ
ン、ピロール、ピラゾール、イミダゾール、チアゾー
ル、オキサゾールなどが挙げられる。その置換基として
は、ハロゲン原子、アルキル基、アルコキシ基、ハロア
ルキル基、ハロアルコキシ基などが挙げられる。
The above-mentioned heterocyclic ring represented by B is a 5- or 6-membered heterocyclic ring containing one or more nitrogen atoms or a condensed heterocyclic ring containing one or more nitrogen atoms, such as pyridine, pyrimidine, Examples thereof include pyridazine, pyrazine, triazine, pyrrole, pyrazole, imidazole, thiazole and oxazole. Examples of the substituent include a halogen atom, an alkyl group, an alkoxy group, a haloalkyl group, a haloalkoxy group and the like.

【0010】R1 の置換基としては、好ましくは低級ア
ルキル基またはハロゲン原子であり、より好ましくはハ
ロゲン原子を表す。R2 の置換基としては、好ましくは
アルキル基を表す。Yは好ましくは−S−を表し、Xは
好ましくは-N(R3 )-を表し、R3 は好ましくは水素原子
または−CHOを表す。Aは好ましくはハロゲン原子、
アルキル基およびハロアルキル基から選ばれた置換基の
一種以上を有するフェニル基を表し、Bは好ましくは無
置換もしくは置換基としてハロゲン原子を有するピリジ
ル基または無置換もしくは置換基としてハロゲン原子を
有するピリミジル基を表す。
The substituent for R 1 is preferably a lower alkyl group or a halogen atom, more preferably a halogen atom. The substituent of R 2 preferably represents an alkyl group. Y preferably represents a -S-, X is preferably -N (R 3) - represents, R 3 preferably represents a hydrogen atom or -CHO. A is preferably a halogen atom,
Represents a phenyl group having at least one substituent selected from an alkyl group and a haloalkyl group, and B is preferably a pyridyl group having an unsubstituted or halogen atom as a substituent, or a pyrimidyl group having an unsubstituted or substituent halogen atom. Represents

【0011】次に、式〔1〕で表される本発明化合物を
第1表に示す。但し、本発明化合物はこれらのみに限定
されるものではない。化合物No. は、後の記載において
参照される。なお各表中のPh はフェニル基を、i はイ
ソを、t はターシャリーを、Etはエチル基を、Prはプロ
ピル基を示す。
The compounds of the present invention represented by the formula [1] are shown in Table 1. However, the compound of the present invention is not limited to these. Compound No. is referred to in the description below. In the tables, Ph represents a phenyl group, i represents iso, t represents tertiary, Et represents ethyl group, and Pr represents propyl group.

【0012】第 1 表Table 1

【0013】[0013]

【化3】 [Chemical 3]

【0014】で表される化合物においてIn the compound represented by

【0015】[0015]

【表1】 ────────────────────────────── 化合物No. R1 2 X Y Wn B ────────────────────────────── 1 Cl CH3 NH S 4-Cl B1 2 Cl CH3 NH S 2,4-Cl2 B1 3 Cl CH3 NH S 3-Cl,4-CH3 B1 4 Cl CH3 NCHO S 4-Cl B1 5 Cl CH3 NH S 4-CH3 B1 6 Cl CH3 NH S 2,4-Cl2 B1 7 Cl CH3 NH S 2,3-Cl2 B1 8 CH3O CH3 NH S 4-Cl B1 9 CH3O CH3 NH S 3-Cl,4-CH3 B1 10 CH3O CH3 NH S 2,4-Cl2 B1 11 CH3O CH3 NH S 2-F,4-CH3 B1 12 CH3O CH3 NH S 3-F,4-CH3 B1 13 CH3O CH3 NCHO S 2,4-Cl2 B1 14 CH3O CH3 NCHO S 3-Cl,4-CH3 B1 15 CH3S CH3 NH S 4-Cl B1 16 CH3S CH3 NH S 3,4-Cl2 B1 17 CH3S CH3 NH S 2,4-Cl2 B1 18 CH3S CH3 NH S 3-Cl,4-CH3 B1 19 CH3S CH3 NH S 2-Cl,4-CH3 B1 20 CH3S CH3 NH S 3-F,4-CH3 B1 21 Cl CH3 NH S 4-Cl B2 22 Cl CH3 NH S 2,4-Cl2 B2 23 Cl CH3 NCH3 S 4-Cl B1 ──────────────────────────────[Table 1] ────────────────────────────── Compound No. R 1 R 2 X Y W n B ──── ────────────────────────── 1 Cl CH 3 NH S 4-Cl B1 2 Cl CH 3 NH S 2,4-Cl 2 B1 3 Cl CH 3 NH S 3-Cl, 4-CH 3 B1 4 Cl CH 3 NCHO S 4-Cl B1 5 Cl CH 3 NH S 4-CH 3 B1 6 Cl CH 3 NH S 2,4-Cl 2 B1 7 Cl CH 3 NH S 2,3-Cl 2 B1 8 CH 3 O CH 3 NH S 4-Cl B1 9 CH 3 O CH 3 NH S 3-Cl, 4-CH 3 B1 10 CH 3 O CH 3 NH S 2, 4-Cl 2 B1 11 CH 3 O CH 3 NH S 2-F, 4-CH 3 B1 12 CH 3 O CH 3 NH S 3-F, 4-CH 3 B1 13 CH 3 O CH 3 NCHO S 2,4 -Cl 2 B1 14 CH 3 O CH 3 NCHO S 3-Cl, 4-CH 3 B1 15 CH 3 S CH 3 NH S 4-Cl B1 16 CH 3 S CH 3 NH S 3,4-Cl 2 B1 17 CH 3 S CH 3 NH S 2,4-Cl 2 B1 18 CH 3 S CH 3 NH S 3-Cl, 4-CH 3 B1 19 CH 3 S CH 3 NH S 2-Cl, 4-CH 3 B1 20 CH 3 S CH 3 NH S 3-F, 4-CH 3 B1 21 C l CH 3 NH S 4-Cl B2 22 Cl CH 3 NH S 2,4-Cl 2 B2 23 Cl CH 3 NCH 3 S 4-Cl B1 ────────────────── ─────────────

【0016】[0016]

【表2】 第 1 表 (続き) ────────────────────────────── 化合物No. R1 2 X Y Wn B ────────────────────────────── 24 Cl CH3 NCH3 S 2,4-Cl2 B1 25 Cl CH3 NCH3 S 3-Cl,4-CH3 B1 26 Cl CH3 NEt S 4-Cl B1 27 Cl CH3 N-i-Pr S 4-CH3 B1 28 Cl Et NH S 2,4-Cl2 B1 29 Cl i-Pr NH S 2,4-Cl2 B1 30 Cl CHF2 NH S 4-Cl B1 31 Cl CHF2 NH S 3-Cl,4-CH3 B1 32 Cl CF3 NH S 2,4-Cl2 B1 33 Cl CF3 NH S 2-F,4-CH3 B1 34 Cl CH3 NSO2CH3 S 3-F,4-CH3 B1 35 Cl CH3 NSO2CH3 S 2,4-Cl2 B1 36 Cl CH3 NSO2CH3 S 3-Cl,4-CH3 B1 37 Cl CH3 NCH3 S 3-Cl,4-CH3 B2 38 Cl CH3 NEt S 4-Cl B2 39 Cl CH3 N-i-Pr S 4-CH3 B2 40 Cl Et NH S 2,4-Cl2 B2 41 Cl i-Pr NH S 2,4-Cl2 B2 42 Cl CHF2 NH S 4-Cl B2 43 Cl CHF2 NH S 3-Cl,4-CH3 B2 44 Cl CF3 NH S 2,4-Cl2 B2 45 Cl CF3 NH S 2-F,4-CH3 B2 ─────────────────────────────[Table 2] Table 1 (continued) ────────────────────────────── Compound No. R 1 R 2 X Y W n B ────────────────────────────── 24 Cl CH 3 NCH 3 S 2,4-Cl 2 B1 25 Cl CH 3 NCH 3 S 3-Cl, 4-CH 3 B1 26 Cl CH 3 NEt S 4-Cl B1 27 Cl CH 3 Ni-Pr S 4-CH 3 B1 28 Cl Et NH S 2,4-Cl 2 B1 29 Cl i -Pr NH S 2,4-Cl 2 B1 30 Cl CHF 2 NH S 4-Cl B1 31 Cl CHF 2 NH S 3-Cl, 4-CH 3 B1 32 Cl CF 3 NH S 2,4-Cl 2 B1 33 Cl CF 3 NH S 2-F, 4-CH 3 B1 34 Cl CH 3 NSO 2 CH 3 S 3-F, 4-CH 3 B1 35 Cl CH 3 NSO 2 CH 3 S 2,4-Cl 2 B1 36 Cl CH 3 NSO 2 CH 3 S 3-Cl, 4-CH 3 B1 37 Cl CH 3 NCH 3 S 3-Cl, 4-CH 3 B2 38 Cl CH 3 NEt S 4-Cl B2 39 Cl CH 3 Ni-Pr S 4-CH 3 B2 40 Cl Et NH S 2,4-Cl 2 B2 41 Cl i-Pr NH S 2,4-Cl 2 B2 42 Cl CHF 2 NH S 4-Cl B2 43 Cl CHF 2 N H S 3-Cl, 4-CH 3 B2 44 Cl CF 3 NH S 2,4-Cl 2 B2 45 Cl CF 3 NH S 2-F, 4-CH 3 B2 ───────────── ─────────────────

【0017】[0017]

【表3】 第 1 表 (続き) ────────────────────────────── 化合物No. R1 2 X Y Wn B ────────────────────────────── 46 Cl CH3 NSO2CH3 S 3-F,4-CH3 B2 47 Cl CH3 NH S 4-Cl B3 48 Cl CH3 NH S 2,4-Cl2 B3 49 Cl CH3 NH S 3-Cl,4-CH3 B4 50 Cl CH3 NH S 4-Cl B4 51 Cl CH3 NH S 4-CH3 B5 52 Cl CH3 NH S 2,4-Cl2 B5 53 Cl CH3 NH S 2,4-Cl2 B6 54 Cl CH3 NH S 4-Cl B6 55 Cl CH3 NH S 3-Cl,4-CH3 B7 56 Cl CH3 NH S 2,4-Cl2 B7 57 Cl CH3 NH S 2-F,4-CH3 B8 58 Cl CH3 NH S 3-F,4-CH3 B9 59 Cl CH3 NH S 2,4-Cl2 B10 60 Cl CH3 NH S 3-Cl,4-CH3 B11 61 Cl CH3 NH S 3-Cl,4-CH3 B12 62 Cl CH3 NH S 4-Cl B13 63 Cl CH3 NH S 4-CH3 B14 64 Cl CH3 NH S 2,4-Cl2 B15 65 Cl CH3 NH S 2,4-Cl2 B16 66 Cl CH3 NH S 4-Cl B16 67 Cl CH3 NH S 3-Cl,4-CH3 B17 ─────────────────────────────[Table 3] Table 1 (continued) ────────────────────────────── Compound No. R 1 R 2 X Y W n B ────────────────────────────── 46 Cl CH 3 NSO 2 CH 3 S 3-F, 4-CH 3 B2 47 Cl CH 3 NH S 4-Cl B3 48 Cl CH 3 NH S 2,4-Cl 2 B3 49 Cl CH 3 NH S 3-Cl, 4-CH 3 B4 50 Cl CH 3 NH S 4-Cl B4 51 Cl CH 3 NH S 4-CH 3 B5 52 Cl CH 3 NH S 2,4-Cl 2 B5 53 Cl CH 3 NH S 2,4-Cl 2 B6 54 Cl CH 3 NH S 4-Cl B6 55 Cl CH 3 NH S 3-Cl, 4-CH 3 B7 56 Cl CH 3 NH S 2,4-Cl 2 B7 57 Cl CH 3 NH S 2-F, 4-CH 3 B8 58 Cl CH 3 NH S 3-F, 4- CH 3 B9 59 Cl CH 3 NH S 2,4-Cl 2 B10 60 Cl CH 3 NH S 3-Cl, 4-CH 3 B11 61 Cl CH 3 NH S 3-Cl, 4-CH 3 B12 62 Cl CH 3 NH S 4-Cl B13 63 Cl CH 3 NH S 4-CH 3 B14 64 Cl CH 3 NH S 2,4-Cl 2 B15 65 Cl CH 3 NH S 2,4-Cl 2 B16 66 Cl CH 3 NH S 4-Cl B16 67 Cl CH 3 NH S 3-Cl, 4-CH 3 B17 ──────────────────────────────

【0018】[0018]

【表4】 第 1 表 (続き) ────────────────────────────── 化合物No. R1 2 X Y Wn B ────────────────────────────── 68 Cl CH3 NH S 2,4-Cl2 B17 69 Cl CH3 NH S 2-F,4-CH3 B18 70 Cl CH3 NH S 3-F,4-CH3 B18 71 CH3 CH3 CH2 S 4-Cl B1 72 CH3 CH3 CH2 S 2,4-Cl2 B1 73 CH3 CH3 CH2 S 2-Cl,4-CH3 B1 74 CH3 CH3 CH2 S 2-F,4-CH3 B1 75 CH3 CH3 CH(OH) S 4-Cl B1 76 CH3 CH3 CH(OH) S 2,4-Cl2 B1 77 CH3 CH3 CH(OH) S 2-Cl,4-CH3 B1 78 CH3 CH3 CH(OH) S 3-Cl,4-CH3 B1 79 CH3 CH3 CH(OH) S 2-F,4-CH3 B1 80 CH3 CH3 CH(OH) S 3-F,4-CH3 B1 81 CH3 CH3 CH(OCH3) S 4-Cl B1 82 CH3 CH3 CH(OCH3) S 2,4-Cl2 B1 83 CH3 CH3 CH(OCOCH3) S 4-Cl B1 84 CH3 CH3 CH(OCOCH3) S 2,4-Cl2 B1 85 CH3 CH3 CH(OCOCH3) S 2-Cl,4-CH3 B1 86 CH3 CH3 CH(OCOCH3) S 2-F,4-CH3 B1 87 CH3 CH3 CH(F) S 4-Cl B1 88 CH3 CH3 CH(F) S 2,4-Cl2 B1 89 CH3 CH3 CH(Cl) S 4-Cl B1 ─────────────────────────────[Table 4] Table 1 (continued) ────────────────────────────── Compound No. R 1 R 2 X Y W n B ────────────────────────────── 68 Cl CH 3 NH S 2,4-Cl 2 B17 69 Cl CH 3 NH S 2-F, 4-CH 3 B18 70 Cl CH 3 NH S 3-F, 4-CH 3 B18 71 CH 3 CH 3 CH 2 S 4-Cl B1 72 CH 3 CH 3 CH 2 S 2,4-Cl 2 B1 73 CH 3 CH 3 CH 2 S 2-Cl, 4-CH 3 B1 74 CH 3 CH 3 CH 2 S 2-F, 4-CH 3 B1 75 CH 3 CH 3 CH (OH) S 4-Cl B1 76 CH 3 CH 3 CH (OH) S 2,4-Cl 2 B1 77 CH 3 CH 3 CH (OH) S 2-Cl, 4-CH 3 B1 78 CH 3 CH 3 CH (OH) S 3-Cl, 4-CH 3 B1 79 CH 3 CH 3 CH (OH) S 2-F, 4-CH 3 B1 80 CH 3 CH 3 CH (OH) S 3-F, 4-CH 3 B1 81 CH 3 CH 3 CH ( OCH 3 ) S 4-Cl B1 82 CH 3 CH 3 CH (OCH 3 ) S 2,4-Cl 2 B1 83 CH 3 CH 3 CH (OCOCH 3 ) S 4-Cl B1 84 CH 3 CH 3 CH (OCOCH 3 ) S 2,4-Cl 2 B1 85 CH 3 CH 3 CH (OCOCH 3 ) S 2-Cl, 4-CH 3 B1 86 CH 3 CH 3 CH (OCOCH 3 ) S 2-F, 4-CH 3 B1 87 CH 3 CH 3 CH (F) S 4-Cl B1 88 CH 3 CH 3 CH (F) S 2,4-Cl 2 B1 89 CH 3 CH 3 CH (Cl) S 4-Cl B1 ────────────────────────── ────

【0019】[0019]

【表5】 第 1 表 (続き) ────────────────────────────── 化合物No. R1 2 X Y Wn B ────────────────────────────── 90 CH3 CH3 CH(Cl) S 2,4-Cl2 B1 91 CH3 CH3 C=O S 4-Cl B1 92 CH3 CH3 C=O S 2,4-Cl2 B1 93 CH3 CH3 C=O S 2-Cl,4-CH3 B1 94 CH3 CH3 C=O S 2-F,4-CH3 B1 95 CH3 CH3 CH2 S 4-Cl B2 96 CH3 CH3 CH2 S 2,4-Cl2 B2 97 CH3 CH3 CH2 S 2-Cl,4-CH3 B2 98 CH3 CH3 CH2 S 2-F,4-CH3 B2 99 CH3 CH3 CH(OH) S 4-Cl B2 100 CH3 CH3 CH(OH) S 2,4-Cl2 B2 101 CH3 CH3 CH(OH) S 2-Cl,4-CH3 B2 102 CH3 CH3 CH(OH) S 3-Cl,4-CH3 B2 103 CH3 CH3 CH(OH) S 2-F,4-CH3 B2 104 CH3 CH3 CH(OH) S 3-F,4-CH3 B2 105 CH3 CH3 CH(OCH3) S 4-Cl B2 106 CH3 CH3 CH(OCH3) S 2,4-Cl2 B2 107 CH3 CH3 CH(OCOCH3) S 4-Cl B2 108 CH3 CH3 CH(OCOCH3) S 2,4-Cl2 B2 109 CH3 CH3 CH(OCOCH3) S 2-Cl,4-CH3 B2 110 CH3 CH3 CH(OCOCH3) S 2-F,4-CH3 B2 111 CH3 CH3 CH(F) S 4-Cl B2 ─────────────────────────────[Table 5] Table 1 (continued) ────────────────────────────── Compound No. R 1 R 2 X Y W n B ────────────────────────────── 90 CH 3 CH 3 CH (Cl) S 2,4-Cl 2 B1 91 CH 3 CH 3 C = OS 4-Cl B1 92 CH 3 CH 3 C = OS 2,4-Cl 2 B1 93 CH 3 CH 3 C = OS 2-Cl, 4-CH 3 B1 94 CH 3 CH 3 C = OS 2-F, 4-CH 3 B1 95 CH 3 CH 3 CH 2 S 4-Cl B2 96 CH 3 CH 3 CH 2 S 2,4-Cl 2 B2 97 CH 3 CH 3 CH 2 S 2-Cl, 4 -CH 3 B2 98 CH 3 CH 3 CH 2 S 2-F, 4-CH 3 B2 99 CH 3 CH 3 CH (OH) S 4-Cl B2 100 CH 3 CH 3 CH (OH) S 2,4-Cl 2 B2 101 CH 3 CH 3 CH (OH) S 2-Cl, 4-CH 3 B2 102 CH 3 CH 3 CH (OH) S 3-Cl, 4-CH 3 B2 103 CH 3 CH 3 CH (OH) S 2-F, 4-CH 3 B2 104 CH 3 CH 3 CH (OH) S 3-F, 4-CH 3 B2 105 CH 3 CH 3 CH (OCH 3 ) S 4-Cl B2 106 CH 3 CH 3 CH ( OCH 3 ) S 2,4-Cl 2 B2 107 CH 3 CH 3 CH (OCOCH 3 ) S 4-Cl B2 108 CH 3 CH 3 CH (OCOCH 3 ) S 2,4-Cl 2 B2 109 CH 3 CH 3 CH (OCOCH 3 ) S 2-Cl, 4-CH 3 B2 110 CH 3 CH 3 CH (OCOCH 3 ) S 2-F, 4-CH 3 B2 111 CH 3 CH 3 CH (F) S 4-Cl B2 ──────────────── ─────────────

【0020】[0020]

【表6】 第 1 表 (続き) ────────────────────────────── 化合物No. R1 2 X Y Wn B ────────────────────────────── 112 CH3 CH3 CH(F) S 2,4-Cl2 B2 113 CH3 CH3 CH(Cl) S 4-Cl B2 114 CH3 CH3 CH(Cl) S 2,4-Cl2 B2 115 CH3 CH3 C=O S 4-Cl B2 116 CH3 CH3 C=O S 2,4-Cl2 B2 117 CH3 CH3 C=O S 2-Cl,4-CH3 B2 118 CH3 CH3 C=O S 2-F,4-CH3 B2 119 CH3 CH3 C(CH3)(OH) S 4-Cl B2 120 CH3 CH3 C(CH3)(OH) S 2,4-Cl2 B2 121 CH3 CH3 C(CH3)(OCOCH3) S 4-Cl B2 122 CH3 CH3 C(CH3)(OCOCH3) S 2,4-Cl2 B2 123 CH3 CH3 C(CH3)(F) S 4-Cl B2 124 CH3 CH3 C(CH3)(F) S 2,4-Cl2 B2 125 CH3 CH3 C(Et)(OH) S 4-Cl B2 126 CH3 CH3 C(Et)(OH) S 2,4-Cl2 B2 127 CH3 CH3 C(i-Pr)(OH) S 4-Cl B2 128 CH3 CH3 C(i-Pr)(OH) S 2,4-Cl2 B2 129 CH3 CH3 C(i-Pr)(OH) S 2-Cl,4-CH3 B2 130 CH3 CH3 C(i-Pr)(OH) S 2-F,4-CH3 B2 131 CH3 CH3 CH(CH3) S 4-Cl B2 132 CH3 CH3 CH(CH3) S 2,4-Cl2 B2 133 CH3 CH3 CH(CH3) S 2-Cl,4-CH3 B2 ─────────────────────────────[Table 6] Table 1 (continued) ────────────────────────────── Compound No. R 1 R 2 X Y W n B ────────────────────────────── 112 CH 3 CH 3 CH (F) S 2,4-Cl 2 B2 113 CH 3 CH 3 CH (Cl) S 4-Cl B2 114 CH 3 CH 3 CH (Cl) S 2,4-Cl 2 B2 115 CH 3 CH 3 C = OS 4-Cl B2 116 CH 3 CH 3 C = OS 2,4-Cl 2 B2 117 CH 3 CH 3 C = OS 2-Cl, 4-CH 3 B2 118 CH 3 CH 3 C = OS 2-F, 4-CH 3 B2 119 CH 3 CH 3 C (CH 3 ) (OH) S 4-Cl B2 120 CH 3 CH 3 C (CH 3 ) (OH) S 2,4-Cl 2 B2 121 CH 3 CH 3 C (CH 3 ) (OCOCH 3 ) S 4-Cl B2 122 CH 3 CH 3 C (CH 3 ) (OCOCH 3 ) S 2,4-Cl 2 B2 123 CH 3 CH 3 C (CH 3 ) (F) S 4-Cl B2 124 CH 3 CH 3 C (CH 3 ) ( F) S 2,4-Cl 2 B2 125 CH 3 CH 3 C (Et) (OH) S 4-Cl B2 126 CH 3 CH 3 C (Et) (OH) S 2,4-Cl 2 B2 127 CH 3 CH 3 C (i-Pr) (OH) S 4-Cl B2 128 CH 3 CH 3 C (i-Pr) (OH) S 2,4-Cl 2 B2 129 CH 3 CH 3 C (i-Pr) (OH) S 2-Cl, 4-CH 3 B2 130 CH 3 CH 3 C (i-Pr) (OH) S 2-F, 4-CH 3 B2 131 CH 3 CH 3 CH (CH 3 ) S 4-Cl B2 132 CH 3 CH 3 CH (CH 3 ) S 2,4- Cl 2 B2 133 CH 3 CH 3 CH (CH 3 ) S 2-Cl, 4-CH 3 B2 ──────────────────────────── ──

【0021】[0021]

【表7】 第 1 表 (続き) ─────────────────────────────── 化合物No. R1 2 X Y Wn B ─────────────────────────────── 134 CH3 CH3 CH(CH3) S 2-F,4-CH3 B2 135 Cl CH3 CH2 S 4-Cl B2 136 Cl CH3 CH2 S 2,4-Cl2 B2 137 Cl CH3 CH2 S 2-Cl,4-CH3 B2 138 Cl CH3 CH2 S 2-F,4-CH3 B2 139 CH3O CH3 CH2 S 4-Cl B2 140 CH3O CH3 CH2 S 2,4-Cl2 B2 141 CH3O CH3 CH2 S 2-Cl,4-CH3 B2 142 CH3O CH3 CH2 S 2-F,4-CH3 B2 143 CH3 CH3 NH S 4-Cl B19 144 CH3 CH3 NH S 2-Cl B19 145 CH3 CH3 NH S 2,4-Cl2 B19 146 CH3 CH3 NH S 3-Cl,4-CH3 B19 147 CH3 CH3 NH S 2-Cl,4-CH3 B19 148 CH3 CH3 NH O 4-Cl B20 149 CH3 CH3 NH S 2-Cl B20 150 CH3 CH3 NH S 2,4-Cl2 B20 151 CH3 CH3 NH S 3-Cl,4-CH3 B20 152 CH3 CH3 NH S 2-Cl,4-CH3 B20 153 CH3 CH3 NCHO S 4-Cl B19 154 CH3 CH3 NCHO S 2-Cl B19 155 CH3 CH3 NCHO S 2,4-Cl2 B19 ─────────────────────────────[Table 7] Table 1 (continued) ─────────────────────────────── Compound No. R 1 R 2 X Y W n B ─────────────────────────────── 134 CH 3 CH 3 CH (CH 3 ) S 2-F, 4 -CH 3 B2 135 Cl CH 3 CH 2 S 4-Cl B2 136 Cl CH 3 CH 2 S 2,4-Cl 2 B2 137 Cl CH 3 CH 2 S 2-Cl, 4-CH 3 B2 138 Cl CH 3 CH 2 S 2-F, 4-CH 3 B2 139 CH 3 O CH 3 CH 2 S 4-Cl B2 140 CH 3 O CH 3 CH 2 S 2,4-Cl 2 B2 141 CH 3 O CH 3 CH 2 S 2 -Cl, 4-CH 3 B2 142 CH 3 O CH 3 CH 2 S 2-F, 4-CH 3 B2 143 CH 3 CH 3 NH S 4-Cl B19 144 CH 3 CH 3 NH S 2-Cl B19 145 CH 3 CH 3 NH S 2,4-Cl 2 B19 146 CH 3 CH 3 NH S 3-Cl, 4-CH 3 B19 147 CH 3 CH 3 NH S 2-Cl, 4-CH 3 B19 148 CH 3 CH 3 NH O 4-Cl B20 149 CH 3 CH 3 NH S 2-Cl B20 150 CH 3 CH 3 NH S 2,4-Cl 2 B20 151 CH 3 CH 3 NH S 3-Cl, 4-CH 3 B20 152 CH 3 CH 3 NH S 2-Cl, 4-CH 3 B20 153 CH 3 CH 3 NCHO S 4-Cl B19 154 CH 3 CH 3 NCHO S 2-Cl B19 155 CH 3 CH 3 NCHO S 2,4-Cl 2 B19 ──────────────────────────────

【0022】[0022]

【表8】 第 1 表 (続き) ─────────────────────────────── 化合物No. R1 2 X Y Wn B ─────────────────────────────── 156 CH3 CH3 NCHO S 3-Cl,4-CH3 B19 157 CH3 CH3 NCHO S 2-Cl,4-CH3 B19 158 CH3 C2H5 NH S 4-Cl B19 159 CH3 C2H5 NH S 2-Cl B19 160 CH3 C2H5 NH S 2,4-Cl2 B19 161 CH3 C2H5 NH S 3-Cl,4-CH3 B19 162 CH3 C2H5 NH S 2-Cl,4-CH3 B19 163 CH3 C2H5 NH S 2-F,4-CH3 B19 164 CH3 C2H5 NH S 3-F,4-CH3 B19 165 CF3 CH3 NH S 2,4-Cl2 B19 166 CF3 CH3 NH S 2,4-Cl2 B20 167 Cl CH3 NH S 3,4-Cl2 B1 168 Cl CH3 NH S 3-F,4-CH3 B1 169 Cl CH3 NH S 3-Cl,4-F B1 170 Cl CH3 NH S 3-F,4-OCH3 B1 171 Cl CH3 NH S 3-Cl,4-OCH3 B1 172 Cl CH3 NH S 2-Cl,4-CH3 B1 173 Cl CH3 NH S 2-F,4-Br B1 174 Cl CH3 NH S 2-F,4-Cl B1 175 Cl CH3 NH S 2-F,4-CH3 B1 176 Cl CH3 NH S 2,3,4-Cl3 B1 177 Cl CH3 NH S 4-CH3 B2 ─────────────────────────────[Table 8] Table 1 (continued) ─────────────────────────────── Compound No. R 1 R 2 X Y W n B ─────────────────────────────── 156 CH 3 CH 3 NCHO S 3-Cl, 4-CH 3 B19 157 CH 3 CH 3 NCHO S 2-Cl, 4-CH 3 B19 158 CH 3 C 2 H 5 NH S 4-Cl B19 159 CH 3 C 2 H 5 NH S 2-Cl B19 160 CH 3 C 2 H 5 NH S 2,4-Cl 2 B19 161 CH 3 C 2 H 5 NH S 3-Cl, 4-CH 3 B19 162 CH 3 C 2 H 5 NH S 2-Cl, 4-CH 3 B19 163 CH 3 C 2 H 5 NH S 2-F, 4-CH 3 B19 164 CH 3 C 2 H 5 NH S 3-F, 4-CH 3 B19 165 CF 3 CH 3 NH S 2,4-Cl 2 B19 166 CF 3 CH 3 NH S 2,4-Cl 2 B20 167 Cl CH 3 NH S 3,4-Cl 2 B1 168 Cl CH 3 NH S 3-F, 4-CH 3 B1 169 Cl CH 3 NH S 3-Cl, 4-F B1 170 Cl CH 3 NH S 3-F, 4-OCH 3 B1 171 Cl CH 3 NH S 3-Cl, 4-OCH 3 B1 172 Cl CH 3 NH S 2-Cl, 4-CH 3 B1 173 Cl CH 3 NH S 2-F, 4-Br B1 174 Cl CH 3 NH S 2-F, 4-Cl B1 175 Cl CH 3 NH S 2-F, 4-CH 3 B1 176 Cl CH 3 NH S 2,3 , 4-Cl 3 B1 177 Cl CH 3 NH S 4-CH 3 B2 ──────────────────────────────

【0023】[0023]

【表9】 第 1 表 (続き) ─────────────────────────────── 化合物No. R1 2 X Y Wn B ─────────────────────────────── 178 Cl CH3 NH S 3,4-Cl2 B2 179 Cl CH3 NH S 2-Cl-4-CH3 B2 180 Cl CH3 NH S 3-Cl-4-CH3 B2 181 Cl CH3 NH S 2-F,4-Cl B2 182 Cl CH3 NH S 2-F,4-CH3 B2 183 Cl CH3 NH S 3-F,4-CH3 B2 184 Cl CH3 NH S 3-CH3,4-CH3 B2 185 Cl CH3 NH S 2-F,5-CH3 B2 186 Cl CH3 NH S 3-Cl-4-F B2 187 Cl CH3 NCHO S 4-CH3 B1 188 Cl CH3 NCHO S 3,4-Cl2 B1 189 Cl CH3 NCHO S 3-F,4-CH3 B1 190 Cl CH3 NCHO S 2,3,4-Cl3 B1 191 Cl CH3 NCHO S 3-F,4-CH3 B2 192 Cl CH3 NH S 2-Cl B19 193 Cl CH3 NH S 4-Cl B19 194 Cl CH3 NH SO 4-CH3 B19 195 Cl CH3 NH SO2 4-CF3 B19 196 Cl CH3 NH S 4-OCH3 B19 197 Cl CH3 NH S 2,4-Cl2 B19 198 Cl CH3 NH S 2-Cl,4-CH3 B19 199 Cl CH3 NH S 3-Cl,4-CH3 B19 ─────────────────────────────[Table 9] Table 1 (continued) ─────────────────────────────── Compound No. R 1 R 2 X Y W n B ─────────────────────────────── 178 Cl CH 3 NH S 3,4-Cl 2 B2 179 Cl CH 3 NH S 2-Cl-4-CH 3 B2 180 Cl CH 3 NH S 3-Cl-4-CH 3 B2 181 Cl CH 3 NH S 2-F, 4-Cl B2 182 Cl CH 3 NH S 2-F , 4-CH 3 B2 183 Cl CH 3 NH S 3-F, 4-CH 3 B2 184 Cl CH 3 NH S 3-CH 3 , 4-CH 3 B2 185 Cl CH 3 NH S 2-F, 5-CH 3 B2 186 Cl CH 3 NH S 3-Cl-4-F B2 187 Cl CH 3 NCHO S 4-CH 3 B1 188 Cl CH 3 NCHO S 3,4-Cl 2 B1 189 Cl CH 3 NCHO S 3-F, 4-CH 3 B1 190 Cl CH 3 NCHO S 2,3,4-Cl 3 B1 191 Cl CH 3 NCHO S 3-F, 4-CH 3 B2 192 Cl CH 3 NH S 2-Cl B19 193 Cl CH 3 NH S 4-Cl B19 194 Cl CH 3 NH SO 4-CH 3 B19 195 Cl CH 3 NH SO 2 4-CF 3 B19 196 Cl CH 3 NH S 4-OCH 3 B19 197 Cl CH 3 NH S 2,4-Cl 2 B19 198 Cl CH 3 NH S 2-Cl, 4-CH 3 B19 199 Cl CH 3 NH S 3-Cl, 4- CH 3 B19 ──────────────────────────────

【0024】[0024]

【表10】 第 1 表 (続き) ─────────────────────────────── 化合物No. R1 2 X Y Wn B ─────────────────────────────── 200 Cl CH3 NH S 2-F,4-Cl B19 201 Cl CH3 NH S 2-F,4-CH3 B19 202 Cl CH3 NH S 2,3,4-Cl3 B19 203 Cl CH3 NCHO S H B19 204 Cl CH3 NCHO S 2-Cl B19 205 Cl CH3 NCHO S 4-Cl B19 206 Cl CH3 NCHO S 4-CH3 B19 207 Cl CH3 NCHO S 4-CF3 B19 208 Cl CH3 NCHO S 4-OCH3 B19 209 Cl CH3 NCHO S 2,4-Cl2 B19 210 Cl CH3 NCHO S 2-Cl,4-CH3 B19 211 Cl CH3 NCHO S 3-Cl,4-CH3 B19 212 Cl CH3 NCHO S 2-F,4-Cl B19 213 Cl CH3 NCHO S 2-F,4-CH3 B19 214 Cl CH3 NCHO S 2,3,4-Cl3 B19 215 Cl CH3 NH S H B20 216 Cl CH3 NH S 2-Cl B20 217 Cl CH3 NH S 4-Cl B20 218 Cl CH3 NH S 4-CH3 B20 219 Cl CH3 NH S 4-CF3 B20 220 Cl CH3 NH S 4-OCH3 B20 221 Cl CH3 NH S 2,4-Cl2 B20 ─────────────────────────────[Table 10] Table 1 (continued) ─────────────────────────────── Compound No. R 1 R 2 X Y W n B ─────────────────────────────── 200 Cl CH 3 NH S 2-F, 4-Cl B19 201 Cl CH 3 NH S 2-F, 4-CH 3 B19 202 Cl CH 3 NH S 2,3,4-Cl 3 B19 203 Cl CH 3 NCHO SH B19 204 Cl CH 3 NCHO S 2-Cl B19 205 Cl CH 3 NCHO S 4-Cl B19 206 Cl CH 3 NCHO S 4-CH 3 B19 207 Cl CH 3 NCHO S 4-CF 3 B19 208 Cl CH 3 NCHO S 4-OCH 3 B19 209 Cl CH 3 NCHO S 2,4-Cl 2 B19 210 Cl CH 3 NCHO S 2-Cl, 4-CH 3 B19 211 Cl CH 3 NCHO S 3-Cl, 4-CH 3 B19 212 Cl CH 3 NCHO S 2-F, 4-Cl B19 213 Cl CH 3 NCHO S 2-F, 4-CH 3 B19 214 Cl CH 3 NCHO S 2,3,4-Cl 3 B19 215 Cl CH 3 NH SH B20 216 Cl CH 3 NH S 2-Cl B20 217 Cl CH 3 NH S 4- Cl B20 218 Cl CH 3 NH S 4-CH 3 B20 21 Cl CH 3 NH S 4-CF 3 B20 220 Cl CH 3 NH S 4-OCH 3 B20 221 Cl CH 3 NH S 2,4-Cl 2 B20 ──────────────── ─────────────

【0025】[0025]

【表11】 第 1 表 (続き) ─────────────────────────────── 化合物No. R1 2 X Y Wn B ─────────────────────────────── 222 Cl CH3 NH S 2-Cl,4-CH3 B20 223 Cl CH3 NH S 3-Cl,4-CH3 B20 224 Cl CH3 NH S 2-F,4-Cl B20 225 Cl CH3 NH S 2-F,4-CH3 B20 226 Cl CH3 NH S 2,3,4-Cl3 B20 227 Cl CH3 NCHO S H B20 228 Cl CH3 NCHO S 2-Cl B20 229 Cl CH3 NCHO S 4-Cl B20 230 Cl CH3 NCHO S 4-CH3 B20 231 Cl CH3 NCHO S 4-CF3 B20 232 Cl CH3 NCHO S 4-OCH3 B20 233 Cl CH3 NCHO S 2,4-Cl2 B20 234 Cl CH3 NCHO S 2-Cl,4-CH3 B20 235 Cl CH3 NCHO S 3-Cl,4-CH3 B20 236 Cl CH3 NCHO S 2-F,4-Cl B20 237 Cl CH3 NCHO S 2-F,4-CH3 B20 238 Cl CH3 NCHO S 2,3,4-Cl3 B20 239 Br CH3 NH S H B19 240 Br CH3 NH S 2-Cl B19 241 Br CH3 NH S 2,4-Cl2 B19 242 Br CH3 NH S 3-Cl,4-CH3 B19 243 Br CH3 NH S 3-F,4-CH3 B19 ─────────────────────────────[Table 11] Table 1 (continued) ─────────────────────────────── Compound No. R 1 R 2 X Y W n B ─────────────────────────────── 222 Cl CH 3 NH S 2-Cl, 4-CH 3 B20 223 Cl CH 3 NH S 3-Cl, 4-CH 3 B20 224 Cl CH 3 NH S 2-F, 4-Cl B20 225 Cl CH 3 NH S 2-F, 4-CH 3 B20 226 Cl CH 3 NH S 2 , 3,4-Cl 3 B20 227 Cl CH 3 NCHO SH B20 228 Cl CH 3 NCHO S 2-Cl B20 229 Cl CH 3 NCHO S 4-Cl B20 230 Cl CH 3 NCHO S 4-CH 3 B20 231 Cl CH 3 NCHO S 4-CF 3 B20 232 Cl CH 3 NCHO S 4-OCH 3 B20 233 Cl CH 3 NCHO S 2,4-Cl 2 B20 234 Cl CH 3 NCHO S 2-Cl, 4-CH 3 B20 235 Cl CH 3 NCHO S 3-Cl, 4-CH 3 B20 236 Cl CH 3 NCHO S 2-F, 4-Cl B20 237 Cl CH 3 NCHO S 2-F, 4-CH 3 B20 238 Cl CH 3 NCHO S 2,3, 4-Cl 3 B20 239 Br CH 3 NH SH B19 240 Br CH 3 NH S 2-Cl 19 241 Br CH 3 NH S 2,4 -Cl 2 B19 242 Br CH 3 NH S 3-Cl, 4-CH 3 B19 243 Br CH 3 NH S 3-F, 4-CH 3 B19 ────── ───────────────────────

【0026】[0026]

【表12】 第 1 表 (続き) ─────────────────────────────── 化合物No. R1 2 X Y Wn B ─────────────────────────────── 244 Br CH3 NH S 2,3,4-Cl3 B19 245 Br CH3 NCHO S 4-Cl B19 246 Br CH3 NCHO S 2,4-Cl2 B19 247 Br CH3 NH S 2,4-Cl2 B20 248 Br CH3 NH S 3-Cl,4-CH3 B20 249 Br CH3 NH S 3-Cl,4-CH3 B21 250 Br CH3 NH S 3-F,4-CH3 B21 251 Br CH3 NH S 4-Cl B22 252 Br CH3 NH S 2,4-Cl2 B22 253 Br CH3 NH S 2,4-Cl2 B23 254 Br CH3 NH S 3-F,4-CH3 B23 255 Br CH3 NH S 2,4-Cl2 B24 256 Br CH3 NH S 3-Cl,4-CH3 B24 257 Br CH3 NH S 3-F,4-CH3 B25 258 Br CH3 NH S 2,3,4-Cl3 B25 259 Br CH3 NH S 2,4-Cl2 B26 260 F CH3 NH S 2,4-Cl2 B19 261 F CH3 NH S 3-Cl,4-CH3 B20 262 F CH3 NH S 3-Cl,4-CH3 B21 263 CH3 CH3 NH S 2,4-Cl2 B21 264 CH3 CH3 NH S 3-Cl,4-CH3 B21 265 CH3 CH3 NH S 3-F,4-CH3 B21 ─────────────────────────────[Table 12] Table 1 (continued) ─────────────────────────────── Compound No. R 1 R 2 X Y W n B ─────────────────────────────── 244 Br CH 3 NH S 2,3,4-Cl 3 B19 245 Br CH 3 NCHO S 4-Cl B19 246 Br CH 3 NCHO S 2,4-Cl 2 B19 247 Br CH 3 NH S 2,4-Cl 2 B20 248 Br CH 3 NH S 3-Cl, 4-CH 3 B20 249 Br CH 3 NH S 3-Cl, 4-CH 3 B21 250 Br CH 3 NH S 3-F, 4-CH 3 B21 251 Br CH 3 NH S 4-Cl B22 252 Br CH 3 NH S 2,4- Cl 2 B22 253 Br CH 3 NH S 2,4-Cl 2 B23 254 Br CH 3 NH S 3-F, 4-CH 3 B23 255 Br CH 3 NH S 2,4-Cl 2 B24 256 Br CH 3 NH S 3-Cl, 4-CH 3 B24 257 Br CH 3 NH S 3-F, 4-CH 3 B25 258 Br CH 3 NH S 2,3,4-Cl 3 B25 259 Br CH 3 NH S 2,4-Cl 2 B26 260 F CH 3 NH S 2,4-Cl 2 B19 261 F CH 3 NH S 3-Cl, 4-CH 3 B20 262 F CH 3 NH S 3-Cl, 4 -CH 3 B21 263 CH 3 CH 3 NH S 2,4-Cl 2 B21 264 CH 3 CH 3 NH S 3-Cl, 4-CH 3 B21 265 CH 3 CH 3 NH S 3-F, 4-CH 3 B21 ─────────────────────────────

【0027】[0027]

【表13】 第 1 表 (続き) ─────────────────────────────── 化合物No. R1 2 X Y Wn B ─────────────────────────────── 266 CH3 CH3 NH S 2-F,4-CH3 B21 267 CH3 CH3 NH S 2-Cl,4-CH3 B21 268 Cl CH3 NH S 2,4-Cl2 B21 269 Cl CH3 NH S 3-Cl,4-CH3 B21 270 CH3 CH3 NH S 4-Cl B22 271 CH3 CH3 NH S 2,4-Cl2 B22 272 CH3 CH3 NH S 3-Cl,4-CH3 B22 273 Cl CH3 NH S 2,4-Cl2 B22 274 Cl CH3 NH S 3-Cl,4-CH3 B22 275 CH3 CH3 NH S 2,4-Cl2 B23 276 CH3 CH3 NH S 3-Cl,4-CH3 B23 277 CH3 CH3 NH S 2-F,4-Cl B23 278 CH3 CH3 NH S 3-F,4-CH3 B23 279 Cl CH3 NH S 3-Cl,4-CH3 B23 280 CH3 CH3 NH S 2,4-Cl2 B24 281 CH3 CH3 NH S 3-Cl,4-CH3 B24 282 Cl CH3 NH S 2,4-Cl2 B24 283 Cl CH3 NH S 3-Cl,4-CH3 B24 284 CH3 CH3 NH S 2,4-Cl2 B25 285 Cl CH3 NH S 3-Cl,4-CH3 B25 286 CH3 CH3 NH S 2,4-Cl2 B26 ─────────────────────────────── 上記表中において、B1−B26は以下の化学構造を表
す。
[Table 13] Table 1 (continued) ─────────────────────────────── Compound No. R 1 R 2 X Y W n B ─────────────────────────────── 266 CH 3 CH 3 NH S 2-F, 4-CH 3 B21 267 CH 3 CH 3 NH S 2-Cl, 4-CH 3 B21 268 Cl CH 3 NH S 2,4-Cl 2 B21 269 Cl CH 3 NH S 3-Cl, 4-CH 3 B21 270 CH 3 CH 3 NH S 4-Cl B22 271 CH 3 CH 3 NH S 2,4-Cl 2 B22 272 CH 3 CH 3 NH S 3-Cl, 4-CH 3 B22 273 Cl CH 3 NH S 2,4-Cl 2 B22 274 Cl CH 3 NH S 3-Cl, 4-CH 3 B22 275 CH 3 CH 3 NH S 2,4-Cl 2 B23 276 CH 3 CH 3 NH S 3-Cl, 4-CH 3 B23 277 CH 3 CH 3 NH S 2-F, 4-Cl B23 278 CH 3 CH 3 NH S 3-F, 4-CH 3 B23 279 Cl CH 3 NH S 3-Cl, 4-CH 3 B23 280 CH 3 CH 3 NH S 2,4- Cl 2 B24 281 CH 3 CH 3 NH S 3-Cl, 4-CH 3 B24 282 Cl CH 3 NH S 2,4-Cl 2 B24 283 Cl CH 3 NH S 3-Cl, 4-CH 3 B2 4 284 CH 3 CH 3 NH S 2,4-Cl 2 B25 285 Cl CH 3 NH S 3-Cl, 4-CH 3 B25 286 CH 3 CH 3 NH S 2,4-Cl 2 B26 ────── ───────────────────────── In the above table, B1-B26 represent the following chemical structures.

【0028】[0028]

【化4】 [Chemical 4]

【0029】[0029]

【化5】 [Chemical 5]

【0030】[0030]

【化6】 [Chemical 6]

【0031】[0031]

【化7】 [Chemical 7]

【0032】次に本発明化合物の製造法を反応スキーム
で示し、以下に説明する。
Next, a method for producing the compound of the present invention is shown in a reaction scheme and explained below.

【0033】反応スキーム (製法1) Reaction scheme (Production method 1)

【0034】[0034]

【化8】 [Chemical 8]

【0035】(製法2)(Production method 2)

【0036】[0036]

【化9】 [Chemical 9]

【0037】(製法3)(Production method 3)

【0038】[0038]

【化10】 [Chemical 10]

【0039】(製法4)(Production method 4)

【0040】[0040]

【化11】 [Chemical 11]

【0041】(製法1) 式〔2〕:(Production Method 1) Formula [2]:

【0042】[0042]

【化12】 [Chemical 12]

【0043】〔式中、R1、R2、YおよびAは前記と同じ
意味を表し、Xは-N(R3)- を表す。〕で示される置換ピ
ラゾールと式〔3〕: L−B 〔3〕 〔式中、Lはハロゲン原子等の脱離基を表し、Bは前記
と同じ意味を表す。〕で示される複素環とを反応させる
ことによって本発明化合物を製造することができる。こ
の際に式〔2〕のXが-NCOR4または-NSO2R5 である時
は、後処理等において加水分解をうけ、生成物のXが -
NHで得られる場合もある。
[In the formula, R 1 , R 2 , Y and A have the same meanings as described above, and X represents -N (R 3 )-. And a substituted pyrazole represented by the formula [3]: LB [3] [In the formula, L represents a leaving group such as a halogen atom, and B represents the same meaning as described above. ] The compound of the present invention can be produced by reacting with a heterocycle represented by At this time, when X in the formula [2] is —NCOR 4 or —NSO 2 R 5, it is hydrolyzed in the post-treatment and the like, and the product X is
Sometimes it can be obtained in NH.

【0044】上記反応に於いて、溶媒は必ずしも必要で
はないが、用いられる溶媒としては、例えば、トルエ
ン、キシレン、クロルベンゼン等の炭化水素類、ジクロ
ロエタン等のハロゲン化炭化水素類、ジイソプロピルエ
ーテル、ジオキサン等のエーテル類、酢酸エチル等のエ
ステル類、アセトニトリル等のニトリル類、ジメチルス
ルホキシド、ジメチルホルムアミド等の極性溶媒が挙げ
られる。また必要に応じて有機塩基(ピリジン、トリエ
チルアミンなど)や無機塩基(炭酸カリウム、水素化ナ
トリウムなど)を加えてもよい。
In the above reaction, a solvent is not always necessary, but examples of the solvent used include hydrocarbons such as toluene, xylene and chlorobenzene, halogenated hydrocarbons such as dichloroethane, diisopropyl ether and dioxane. And ethers such as ethyl acetate, nitriles such as acetonitrile, and polar solvents such as dimethylsulfoxide and dimethylformamide. If necessary, an organic base (pyridine, triethylamine, etc.) or an inorganic base (potassium carbonate, sodium hydride, etc.) may be added.

【0045】また必要に応じて、銅塩や銅錯体を触媒と
して加えてもよい。上記反応に用いられる試剤の量は、
式〔2〕で示される置換ピラゾール1当量に対して、式
〔3〕で示される複素環は1〜5当量の範囲である。上
記反応に於いて反応温度は任意にとりうるが通常、室温
〜200℃もしくは溶媒の還流温度が好ましい。反応終
了後は通常の後処理を行なうことにより目的物を得るこ
とができる。
If necessary, a copper salt or a copper complex may be added as a catalyst. The amount of reagent used in the above reaction is
The heterocycle represented by the formula [3] is in the range of 1 to 5 equivalents relative to 1 equivalent of the substituted pyrazole represented by the formula [2]. In the above reaction, the reaction temperature can be arbitrarily set, but usually room temperature to 200 ° C. or the reflux temperature of the solvent is preferable. After completion of the reaction, the desired product can be obtained by performing usual post-treatment.

【0046】(製法2) (a) 式〔4〕:(Production Method 2) (a) Formula [4]:

【0047】[0047]

【化13】 [Chemical 13]

【0048】〔式中、R1およびR2は前記と同じ意味を表
し、Xは-N(R3)- を表す。〕で示されるピラゾールと式
〔3〕で示される複素環とを必要に応じて適当な溶媒と
塩基を用いて反応させることによって式〔7〕:
[In the formula, R 1 and R 2 have the same meanings as described above, and X represents -N (R 3 )-. ] The pyrazole represented by the formula [3] and the heterocycle represented by the formula [3] are reacted with a suitable solvent and a base as necessary to obtain the formula [7]:

【0049】[0049]

【化14】 [Chemical 14]

【0050】〔式中、R1、R2、XおよびBは前記と同じ
意味を表す。〕を製造する。この際に式〔4〕のXが-N
COR4または-NSO2R5 である時は、後処理等において加水
分解をうけ、式〔7〕のXが -NHで得られる場合もあ
る。上記反応に於いて、用いられる溶媒としては、例え
ば、トルエン、キシレン、クロルベンゼン等の炭化水素
類、ジクロロエタン等のハロゲン化炭化水素類、ジイソ
プロピルエーテル、ジオキサン等のエーテル類、酢酸エ
チル等のエステル類、アセトニトリル等のニトリル類、
ジメチルスルホキシド、ジメチルホルムアミド等の極性
溶媒が挙げられる。
[In the formula, R 1 , R 2 , X and B have the same meanings as described above. ] Is manufactured. At this time, X in the formula [4] is -N
When it is COR 4 or —NSO 2 R 5 , it may be hydrolyzed in a post-treatment or the like to give X in the formula [7] as —NH. Examples of the solvent used in the above reaction include hydrocarbons such as toluene, xylene and chlorobenzene, halogenated hydrocarbons such as dichloroethane, ethers such as diisopropyl ether and dioxane, and esters such as ethyl acetate. , Nitriles such as acetonitrile,
Examples include polar solvents such as dimethyl sulfoxide and dimethylformamide.

【0051】また用いられる塩基としては、例えば炭酸
カリウム、水素化ナトリウムなどが挙げられる。また必
要に応じて、銅塩や銅錯体等を触媒として加えてもよ
い。上記反応において反応温度は、任意にとりうるが通
常、室温〜200℃もしくは溶媒の還流温度が好まし
い。
Examples of the base used include potassium carbonate, sodium hydride and the like. Moreover, you may add a copper salt, a copper complex, etc. as a catalyst as needed. In the above reaction, the reaction temperature can be arbitrarily set, but usually, room temperature to 200 ° C. or the reflux temperature of the solvent is preferable.

【0052】(b) 式〔5〕:(B) Formula [5]:

【0053】[0053]

【化15】 [Chemical 15]

【0054】〔式中、R1、R2は前記と同じ意味を表し、
Lはハロゲン原子等の脱離基を表す。〕で示されるピラ
ゾールと式〔6〕: HX−B 〔6〕 〔式中、Bは前記と同じ意味を表し、Xは-N(R3)- を表
す。〕で示される複素環とを必要に応じて適当な溶媒と
塩基を用いて反応させることによって式〔7〕:
[In the formula, R 1 and R 2 have the same meanings as described above,
L represents a leaving group such as a halogen atom. And a pyrazole represented by the formula [6]: HX-B [6] [In the formula, B represents the same meaning as described above, and X represents -N (R 3 )-. ] The heterocycle represented by the formula [7]: by reacting with a suitable solvent and a base, if necessary.

【0055】[0055]

【化16】 [Chemical 16]

【0056】〔式中、R1、R2、XおよびBは前記と同じ
意味を表す。〕を製造する。この際に式〔6〕のXが-N
COR4または-NSO2R5 である時は、後処理等において加水
分解をうけ、式〔7〕のXが-NH で得られる場合もあ
る。上記反応に於いて、用いられる溶媒としては、例え
ば、トルエン、キシレン、クロルベンゼン等の炭化水素
類、ジクロロエタン等のハロゲン化炭化水素類、ジイソ
プロピルエーテル、ジオキサン等のエーテル類、酢酸エ
チル等にエステル類、アセトニトリル等のニトリル類、
ジメチルスルホキシド、ジメチルホルムアミド等の極性
溶媒が挙げられる。
[In the formula, R 1 , R 2 , X and B have the same meanings as described above. ] Is manufactured. At this time, X in the formula [6] is -N
When it is COR 4 or —NSO 2 R 5 , it may be hydrolyzed in a post-treatment or the like to obtain X in the formula [7] by —NH 2. Examples of the solvent used in the above reaction include hydrocarbons such as toluene, xylene and chlorobenzene, halogenated hydrocarbons such as dichloroethane, ethers such as diisopropyl ether and dioxane, and esters such as ethyl acetate. , Nitriles such as acetonitrile,
Examples include polar solvents such as dimethyl sulfoxide and dimethylformamide.

【0057】また用いられる塩基としては、炭酸カリウ
ム、水素化ナトリウムなどが挙げられる。また必要に応
じて、銅塩や銅錯体等を触媒として加えてもよい。上記
反応において反応温度は任意にとりうるが通常、室温〜
200℃もしくは溶媒の還流温度が好ましい。
Examples of the base used include potassium carbonate, sodium hydride and the like. Moreover, you may add a copper salt, a copper complex, etc. as a catalyst as needed. In the above reaction, the reaction temperature can be arbitrarily set, but is usually room temperature to
200 ° C. or solvent reflux temperature is preferred.

【0058】次の上記(a) または(b) で得られた式
〔7〕で示されるピラゾールと式〔8〕: A−Y−L 〔8〕 〔式中Aは前記と同じ意味を表し、Yは酸素原子を除く
前記と同じ意味を表し、Lはハロゲン原子等の脱離基を
表す。〕で示される化合物とを必要に応じて適当な溶媒
と塩基を用いて反応させることによって本発明化合物を
製造することができる。
The pyrazole represented by the formula [7] obtained in the following (a) or (b) and the formula [8]: AYL [8] [wherein A represents the same meaning as described above] , Y has the same meaning as described above except for an oxygen atom, and L represents a leaving group such as a halogen atom. ] The compound of the present invention can be produced by reacting the compound shown by the above with a suitable solvent and a base if necessary.

【0059】上記反応に於いて、用いられる溶媒として
は、例えば、トルエン、キシレン、クロルベンゼン等の
炭化水素類、ジクロロエタン、クロロホルム、四塩化炭
素等のハロゲン化炭化水素類、ジイソプロピルエーテ
ル、ジオキサン等のエーテル類、酢酸エチル等のエステ
ル類、アセトニトリル等のニトリル類、ジメチルスルホ
キシド、ジメチルホルムアミド等の極性溶媒が挙げられ
る。
Examples of the solvent used in the above reaction include hydrocarbons such as toluene, xylene and chlorobenzene, halogenated hydrocarbons such as dichloroethane, chloroform and carbon tetrachloride, diisopropyl ether and dioxane. Examples thereof include ethers, esters such as ethyl acetate, nitriles such as acetonitrile, and polar solvents such as dimethyl sulfoxide and dimethylformamide.

【0060】また用いられる塩基としては、ピリジン、
トリエチルアミン、炭酸カリウム等が挙げられる。上記
反応において反応温度は任意にとりうるが、通常0℃〜
100℃が好ましい。 (製法3) X=N−R3 、R3 ≠Hの時 式
The base used is pyridine,
Examples include triethylamine and potassium carbonate. In the above reaction, the reaction temperature can be arbitrarily set, but is usually 0 ° C to
100 ° C. is preferred. (Production method 3) When X = N−R 3 , R 3 ≠ H

〔9〕:[9]:

【0061】[0061]

【化17】 [Chemical 17]

【0062】〔式中、R1、R2、Y、AおよびBは前記と
同じ意味を表す。〕で示されるピラゾールと式〔1
0〕: R3 −L 〔10〕 〔式中、R3は水素原子を除く前記と同じ意味を表し、L
はハロゲン原子等の脱離基を表す。〕で示される化合物
とを必要に応じて適当な溶媒と塩基を用いて反応させる
ことによって本発明化合物を製造することができる。
[In the formula, R 1 , R 2 , Y, A and B have the same meanings as described above. ] And the formula [1
0]: R 3 -L [10] [wherein R 3 has the same meaning as described above except for a hydrogen atom, and L 3
Represents a leaving group such as a halogen atom. ] The compound of the present invention can be produced by reacting the compound shown by the above with a suitable solvent and a base if necessary.

【0063】上記反応に於いて、用いられる溶媒として
は、例えば、ベンゼン、トルエン、キシレン等の炭化水
素類、ジクロロエタン、クロロホルム、四塩化炭素等の
ハロゲン炭化水素類、ジイソプロピルエーテル、テトラ
ヒドロフラン、ジオキサン等のエーテル類、酢酸エチル
等のエステル類、アセトニトリル等のニトリル類、ジメ
チルスルホキシド、ジメチルホルムアミド等の極性溶媒
が挙げられる。
Examples of the solvent used in the above reaction include hydrocarbons such as benzene, toluene and xylene, halogenated hydrocarbons such as dichloroethane, chloroform and carbon tetrachloride, diisopropyl ether, tetrahydrofuran and dioxane. Examples thereof include ethers, esters such as ethyl acetate, nitriles such as acetonitrile, and polar solvents such as dimethyl sulfoxide and dimethylformamide.

【0064】また用いられる塩基としては、ピリジン、
トリエチルアミン等の有機塩基や炭酸カリウム、水素化
ナトリウム等の無機塩基が挙げられる。上記反応におい
て、反応温度は任意にとりうるが、通常0℃〜100℃
が好ましい。
As the base used, pyridine,
Examples thereof include organic bases such as triethylamine and inorganic bases such as potassium carbonate and sodium hydride. In the above reaction, the reaction temperature can be arbitrarily set, but it is usually 0 ° C to 100 ° C.
Is preferred.

【0065】(製法4) X=CH(R4)の時 式〔12〕:(Production Method 4) When X = CH (R 4 ) Formula [12]:

【0066】[0066]

【化18】 [Chemical 18]

【0067】〔式中、R1、R2、Y、A、BおよびR4
前記と同じ意味を表す。〕で示される化合物を適当な還
元剤を用いて反応させることにより、式〔13〕:
[In the formula, R 1 , R 2 , Y, A, B and R 4 have the same meanings as described above. ] The compound of formula [13]: is reacted by using a suitable reducing agent.

【0068】[0068]

【化19】 [Chemical 19]

【0069】〔式中、R1、R2、Y、A、BおよびR4
前記と同じ意味を表す。〕で示される本発明化合物を製
造することができる。上記反応において用いられる還元
剤としては、例えばP2 4 などのリン系化合物が挙げ
られる。
[In the formula, R 1 , R 2 , Y, A, B and R 4 have the same meanings as described above. ] The compound of the present invention represented by Examples of the reducing agent used in the above reaction include phosphorus compounds such as P 2 I 4 .

【0070】[0070]

【実施例】次に具体的な製造例を示す。EXAMPLES Next, specific production examples will be shown.

【0071】〔製造例1〕(本発明化合物No.99の
合成) 2−ピリジル−(1,3−ジメチル−5−ピラゾリ
ル)メタノールの合成 2−ブロモピリジン5.5gを溶解した乾燥テトラヒド
ロフラン溶液300mlを−78℃に冷却し、これにn−
ブチルリチウムヘキサン溶液(15W/W%)5.45
gをゆっくりと滴下し、30分間撹拌した。次に、1,
3−ジメチル−5−ホルミルピラゾール4.2gを−7
8℃でゆっくりと滴下した。この後ゆっくりと室温にま
で昇温し15時間撹拌した。
[Production Example 1] (Synthesis of compound No. 99 of the present invention) Synthesis of 2-pyridyl- (1,3-dimethyl-5-pyrazolyl) methanol 300 ml of dry tetrahydrofuran solution in which 5.5 g of 2-bromopyridine was dissolved Was cooled to -78 ° C and n-
Butyllithium hexane solution (15W / W%) 5.45
g was slowly added dropwise, and the mixture was stirred for 30 minutes. Then 1,
4.2 g of 3-dimethyl-5-formylpyrazole-7
It was slowly added dropwise at 8 ° C. Then, the temperature was slowly raised to room temperature and the mixture was stirred for 15 hours.

【0072】この溶液に2規定の塩酸を加えて中性にし
た後、酢酸エチル150mlで3回抽出した。有機層を無
水硫酸ナトリウムで乾燥し、溶媒を減圧留去して残渣を
シリカゲルカラムクロマトグラフィー(展開液;クロロ
ホルム)で精製することにより、2−ピリジル−(1,
3−ジメチル−5−ピラゾリル)メタノール5.2gを
褐色油状物として得た。
The solution was neutralized by adding 2N hydrochloric acid, and the mixture was extracted 3 times with 150 ml of ethyl acetate. The organic layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solution; chloroform) to give 2-pyridyl- (1,
5.2 g of 3-dimethyl-5-pyrazolyl) methanol were obtained as a brown oil.

【0073】本発明化合物No.99の合成 2−ピリジル−(1,3−ジメチル−5−ピラゾリル)
メタノール3gを溶解した乾燥クロロホルム溶液60ml
に、室温下で4−クロロフェニルスルフェニルクロライ
ド3.4gを滴下し、12時間撹拌した。溶媒を留去し
た後、酢酸エチル50ml、10%炭酸水素ナトリウム水
溶液50mlを加えて30分間撹拌した。有機層を分離し
た後、さらに水層を酢酸エチル50mlで3回抽出した。
合わせた有機層を無水硫酸ナトリウムで乾燥し、溶媒を
減圧留去した後残渣をシリカゲルクロマトグラフィー
(展開液;クロロホルム)で精製することにより、2−
ピリジル−(4−(4−クロロフェニルチオ)−1,3
−ジメチル−5−ピラゾリル)メタノール1.2gを白
色結晶として得た。融点90.0〜91.0℃
Inventive Compound No. Synthesis of 99 2-pyridyl- (1,3-dimethyl-5-pyrazolyl)
60 ml of a dry chloroform solution containing 3 g of methanol
At room temperature, 3.4 g of 4-chlorophenylsulfenyl chloride was added dropwise thereto, and the mixture was stirred for 12 hours. After the solvent was distilled off, 50 ml of ethyl acetate and 50 ml of 10% aqueous sodium hydrogen carbonate solution were added, and the mixture was stirred for 30 minutes. After separating the organic layer, the aqueous layer was extracted three times with 50 ml of ethyl acetate.
The combined organic layers were dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, and the residue was purified by silica gel chromatography (developing solution; chloroform) to give 2-
Pyridyl- (4- (4-chlorophenylthio) -1,3
1.2 g of -dimethyl-5-pyrazolyl) methanol was obtained as white crystals. Melting point 90.0-91.0 ° C

【0074】〔製造例2〕(本発明化合物No.115
の合成) 製造例1で得られた本発明化合物No.99 1.2g
を乾燥ジクロロメタン50mlに溶解した溶液に、室温で
二酸化マンガン1.5gを加え2時間撹拌した。無機物
をセライトで濾別した後溶媒を減圧留去し、残渣をジイ
ソプロピルエーテルで結晶化させることにより2−ピリ
ジル−(4−(4−クロロフェニルチオ)−1,3−ジ
メチル−5−ピラゾリル)ケトン1.0gを白色結晶と
して得た。融点111.0〜113.0℃
Production Example 2 (Compound No. 115 of the present invention)
Synthesis of compound of the present invention obtained in Production Example 1 99 1.2 g
Was dissolved in 50 ml of dry dichloromethane, 1.5 g of manganese dioxide was added at room temperature, and the mixture was stirred for 2 hours. The inorganic material was filtered off through Celite, the solvent was evaporated under reduced pressure, and the residue was crystallized from diisopropyl ether to give 2-pyridyl- (4- (4-chlorophenylthio) -1,3-dimethyl-5-pyrazolyl) ketone. 1.0 g was obtained as white crystals. Melting point 111.0-113.0 ° C

【0075】〔製造例3〕(本発明化合物No.95の
合成) 窒素気流下、四ヨウ化二リン0.5gのベンゼン溶液1
0mlを10分間加熱還流した。この溶液に、製造例1で
得られた本発明化合物No.99(1.2g)を溶解し
たベンゼン溶液30mlを滴下し、16時間加熱還流し
た。空冷後10%亜硫酸水素ナトリウム水溶液5mlを加
え室温にて1時間撹拌した。
[Production Example 3] (Synthesis of Compound No. 95 of the Present Invention) A benzene solution 1 containing 0.5 g of diphosphorus tetraiodide under a nitrogen stream.
0 ml was heated to reflux for 10 minutes. The compound of the present invention No. obtained in Production Example 1 was added to this solution. 30 ml of a benzene solution in which 99 (1.2 g) was dissolved was added dropwise, and the mixture was heated under reflux for 16 hours. After cooling with air, 5 ml of 10% aqueous sodium hydrogen sulfite solution was added, and the mixture was stirred at room temperature for 1 hour.

【0076】この溶液を酢酸エチル50mlで3回抽出
し、有機層を無水硫酸ナトリウムで乾燥した。溶媒を減
圧留去し、残渣をシリカゲルカラムクロマトグラフィー
(展開液;クロロホルム)で精製することにより、4−
(4−クロロフェニルチオ)−1,3−ジメチル−5−
(2−ピリジルメチル)ピラゾール0.34gを得た。
融点80.0〜82.0℃
This solution was extracted 3 times with 50 ml of ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate. The solvent was distilled off under reduced pressure, and the residue was purified by silica gel column chromatography (developing solution; chloroform) to give 4-
(4-chlorophenylthio) -1,3-dimethyl-5-
0.34 g of (2-pyridylmethyl) pyrazole was obtained.
Melting point 80.0-82.0 ° C

【0077】〔製造例4〕(本発明化合物No.22の
合成) 3−クロロ−1−メチル−4−ニトロ−5−(2−
ピリジルアミノ)ピラゾールの合成 水素化ナトリウム4.6g(55%)の懸濁したN,N
−ジメチルホルムアミド100mlに、氷冷下、N−(2
−ピリジル)ホルムアミド11.4gとN,N−ジメチ
ルホルムアミド20mlの混合溶液を滴下し、室温下で約
1時間撹拌した。次に3,5−ジクロロ−1−メチル−
4−ニトロピラゾール17.5gをN,N−ジメチルホ
ルムアミド20mlに溶解した溶液を氷冷下滴下し、その
後60℃で8時間加熱撹拌した。冷却後、N,N−ジメ
チルホルムアミドを減圧留去し、クロロホルムで抽出
し、有機層を炭酸ナトリウム水溶液で洗浄し、続いて水
洗い後、無水硫酸ナトリウムで乾燥した。ろ過後、溶媒
を減圧留去し、残った結晶をイソプロピルエーテルで洗
浄し、ろ過乾燥することにより、目的の3−クロロ−1
−メチル−4−ニトロ−5−(2−ピリジルアミノ)ピ
ラゾール14.2gを得た。融点127.0〜129.
0℃
Production Example 4 (Synthesis of Compound No. 22 of the Present Invention) 3-Chloro-1-methyl-4-nitro-5- (2-
Synthesis of pyridylamino) pyrazole Suspended N, N with 4.6 g (55%) of sodium hydride
-In 100 ml of dimethylformamide, under ice cooling, N- (2
A mixed solution of 11.4 g of -pyridyl) formamide and 20 ml of N, N-dimethylformamide was added dropwise, and the mixture was stirred at room temperature for about 1 hour. Next, 3,5-dichloro-1-methyl-
A solution prepared by dissolving 17.5 g of 4-nitropyrazole in 20 ml of N, N-dimethylformamide was added dropwise under ice cooling, and then the mixture was heated with stirring at 60 ° C. for 8 hours. After cooling, N, N-dimethylformamide was distilled off under reduced pressure and extracted with chloroform. The organic layer was washed with an aqueous sodium carbonate solution, subsequently washed with water and then dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off under reduced pressure, the remaining crystals were washed with isopropyl ether, filtered and dried to give the desired 3-chloro-1.
14.2 g of -methyl-4-nitro-5- (2-pyridylamino) pyrazole were obtained. Melting point 127.0-129.
0 ° C

【0078】 4−アミノ−3−クロロ−1−メチル
−5−(2−ピリジルアミノ)ピラゾールの合成 3−クロロ−1−メチル−4−ニトロ−5−(2−ピリ
ジルアミノ)ピラゾール7gをエタノール50mlと濃塩
酸50mlの混合溶液に加え溶解させた。そこに、室温
下、塩化第一錫2水和物31gとエタノール70mlの混
合溶液を滴下し、80℃で7時間撹拌した。冷却後、氷
水中に反応液を注ぎ、20%水酸化ナトリウム水溶液を
加えてアルカリ性にした。酢酸エチルで抽出し、水洗い
後、無水硫酸ナトリウムで乾燥した。ろ過後、溶媒を減
圧留去することにより、目的の4−アミノ−3−クロロ
−1−メチル−5−(2−ピリジルアミノ)ピラゾール
5.0gを結晶として得た。融点151.0〜153.
0℃
Synthesis of 4-amino-3-chloro-1-methyl-5- (2-pyridylamino) pyrazole 3-chloro-1-methyl-4-nitro-5- (2-pyridylamino) pyrazole 7 g and ethanol 50 ml It was added to a mixed solution of 50 ml of concentrated hydrochloric acid and dissolved. At room temperature, a mixed solution of 31 g of stannous chloride dihydrate and 70 ml of ethanol was added dropwise thereto, and the mixture was stirred at 80 ° C. for 7 hours. After cooling, the reaction solution was poured into ice water, and a 20% aqueous sodium hydroxide solution was added to make the solution alkaline. It was extracted with ethyl acetate, washed with water, and dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off under reduced pressure to obtain 5.0 g of the target 4-amino-3-chloro-1-methyl-5- (2-pyridylamino) pyrazole as crystals. Melting point 151.0-153.
0 ° C

【0079】 3−クロロ−1−メチル−5−(2−
ピリジルアミノ)ピラゾールの合成 4−アミノ−3−クロロ−1−メチル−5−(2−ピリ
ジルアミノ)ピラゾール1.5gをエタノール50mlと
濃硫酸5mlの混合溶液に加えて、加熱還流した。この溶
液に亜硝酸ナトリウム1.1gを少しずつ加えた。この
時窒素ガスの発生が観察された。亜硝酸ナトリウムの添
加終了後、30分加熱還流した。冷却後、20%水酸化
ナトリウム水溶液を加えてアルカリ性にした後、クロロ
ホルムで抽出し、有機層を水洗後、無水硫酸ナトリウム
で乾燥した。ろ過後、溶媒を減圧留去した。残渣をシリ
カゲルカラムクロマトグラフィー(展開液;クロロホル
ム−酢酸エチル)で精製することにより、3−クロロ−
1−メチル−5−(2−ピリジルアミノ)ピラゾール
1.1gを得た。融点105.0〜106.0℃
3-chloro-1-methyl-5- (2-
Synthesis of pyridylamino) pyrazole 1.5 g of 4-amino-3-chloro-1-methyl-5- (2-pyridylamino) pyrazole was added to a mixed solution of 50 ml of ethanol and 5 ml of concentrated sulfuric acid, and the mixture was heated under reflux. 1.1 g of sodium nitrite was added little by little to this solution. At this time, generation of nitrogen gas was observed. After the addition of sodium nitrite was completed, the mixture was heated under reflux for 30 minutes. After cooling, 20% aqueous sodium hydroxide solution was added to make the mixture alkaline, followed by extraction with chloroform. The organic layer was washed with water and dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off under reduced pressure. The residue is purified by silica gel column chromatography (developing solution; chloroform-ethyl acetate) to give 3-chloro-
1.1 g of 1-methyl-5- (2-pyridylamino) pyrazole was obtained. Melting point 105.0-106.0 ° C

【0080】 本発明化合物No.22の合成 3−クロロ−1−メチル−5−(2−ピリジルアミノ)
ピラゾール1.05gを無水クロロホルム30mlに溶解
した。この溶液に2,4−ジクロロフェニルスルフェニ
ルクロライド1.3gを滴下し、室温で3時間撹拌し
た。炭酸ナトリウム水溶液を加えた後、クロロホルムで
抽出し、有機層を水洗後、無水硫酸ナトリウムで乾燥し
た。ろ過後、溶媒を減圧留去し、残渣をシリカゲルカラ
ムクロマトグラフィー(展開液;クロロホルム)で精製
することにより、3−クロロ−4−(2,4−ジクロロ
フェニルチオ)−1−メチル−5−(2−ピリジルアミ
ノ)ピラゾール1.42gを得た。融点147.0〜1
48.0℃
Inventive Compound No. Synthesis of 22 3-chloro-1-methyl-5- (2-pyridylamino)
1.05 g of pyrazole was dissolved in 30 ml of anhydrous chloroform. 1.3 g of 2,4-dichlorophenylsulfenyl chloride was added dropwise to this solution, and the mixture was stirred at room temperature for 3 hours. After adding a sodium carbonate aqueous solution, the mixture was extracted with chloroform, the organic layer was washed with water, and then dried over anhydrous sodium sulfate. After filtration, the solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (developing solution; chloroform) to give 3-chloro-4- (2,4-dichlorophenylthio) -1-methyl-5- (. 1.42 g of 2-pyridylamino) pyrazole was obtained. Melting point 147.0-1
48.0 ° C

【0081】〔製造例5〕(本発明化合物 No.16
8の合成) 5−アミノ−3−クロロ−1−メチル−4−メトキ
シカルボニルピラゾールの合成 3,5−ジクロロ−1−メチル−4−メトキシカルボニ
ルピラゾール100gを無水ジメチルスルホキシド35
0mlに溶解し、続いてナトリウムアジド37.3gを加
え、60℃で3日間攪拌した。反応液を氷水800mlに
注ぎ折出した結晶をろ過し、水で洗浄を行った。結晶を
乾燥させることにより、5−アジド−3−クロロ−1−
メチル−4−メトキシカルボニルピラゾールの約65%
含有物が81.5g得られた。この混合物に無水メタノ
ール400mlとピペリジン1.5gを加え、氷水で約1
5℃まで冷却した。そこに硫化水素ガスを約1時間吹き
込んだ。続いて窒素ガスを約15分間吹き込み過剰の硫
化水素ガスを除去した。折出している硫黄をろ過で除
き、溶媒を減圧留去した。残渣にクロロホルム150ml
と飽和炭酸ナトリウム水溶液50mlを加え、30分攪拌
した。クロロホルム抽出、水洗い後、無水硫酸ナトリウ
ムで乾燥した。ろ過、溶媒留去後、残渣をシリカゲルカ
ラムクロマトグラフィー(展開液;クロロホルム−エタ
ノール)で精製することにより、淡黄色の結晶として5
−アミノ−3−クロロ−1−メチル−4−メトキシカル
ボニルピラゾールが47.1g(収率52%)得られ
た。融点 104.0〜105.0℃
[Production Example 5] (Inventive compound No. 16)
Synthesis of 8-) Synthesis of 5-amino-3-chloro-1-methyl-4-methoxycarbonylpyrazole 100 g of 3,5-dichloro-1-methyl-4-methoxycarbonylpyrazole was added to anhydrous dimethyl sulfoxide 35.
It was dissolved in 0 ml, subsequently 37.3 g of sodium azide was added, and the mixture was stirred at 60 ° C. for 3 days. The reaction solution was poured into 800 ml of ice water, and the separated crystals were filtered and washed with water. By drying the crystals, 5-azido-3-chloro-1-
About 65% of methyl-4-methoxycarbonylpyrazole
81.5 g of inclusions were obtained. To this mixture, 400 ml of anhydrous methanol and 1.5 g of piperidine were added, and ice water was added to about 1
Cooled to 5 ° C. Hydrogen sulfide gas was blown therein for about 1 hour. Subsequently, nitrogen gas was blown for about 15 minutes to remove excess hydrogen sulfide gas. The protruding sulfur was removed by filtration, and the solvent was distilled off under reduced pressure. 150 ml of chloroform on the residue
And 50 ml of saturated aqueous sodium carbonate solution were added, and the mixture was stirred for 30 minutes. After extraction with chloroform, washing with water, and drying with anhydrous sodium sulfate. After filtration and evaporation of the solvent, the residue was purified by silica gel column chromatography (developing solution; chloroform-ethanol) to give 5 as pale yellow crystals.
47.1 g (yield 52%) of -amino-3-chloro-1-methyl-4-methoxycarbonylpyrazole was obtained. Melting point 104.0-105.0 ° C

【0082】 5−アミノ−3−クロロ−1−メチル
ピラゾールの合成 5−アミノ−3−クロロ−1−メチル−4−メトキシカ
ルボニルピラゾール55.5gを水酸化ナトリウム3
1.4gを溶解したメタノール200mlと水250mlの
混合水溶液に加え、加熱還流を3時間行った。冷却後、
減圧下溶媒を留去した。水を300ml加え、塩酸(31
%)を加えてpH2の酸性にした。折出した結晶をろ過
し、水洗後乾燥することにより(5−アミノ−3−クロ
ロ−1−メチル−4−ピラゾリル)カルボン酸の白色結
晶が約50g得られた。
Synthesis of 5-amino-3-chloro-1-methylpyrazole 5-amino-3-chloro-1-methyl-4-methoxycarbonylpyrazole 55.5 g was added to sodium hydroxide 3
1.4 g of the solution was added to a mixed aqueous solution of 200 ml of methanol and 250 ml of water, and the mixture was heated under reflux for 3 hours. After cooling
The solvent was distilled off under reduced pressure. Add 300 ml of water and add hydrochloric acid (31
%) To acidify to pH 2. The separated crystals were filtered, washed with water and dried to obtain about 50 g of white crystals of (5-amino-3-chloro-1-methyl-4-pyrazolyl) carboxylic acid.

【0083】次に、塩酸(31%)100mlと水50ml
の混合水溶液を80℃に加熱攪拌しているところへ、上
記の結晶を少しずつ加えた。(炭酸ガスの発生が見られ
た。)結晶を加え終えてから、さらに80℃で3時間攪
拌を行った。続いて減圧下、水を約半分留去した後、水
酸化カリウム水溶液を加えてpH11位のアルカリ性に
した。また減圧下水を完全に留去したところへアセトニ
トリル300mlを加え、無水硫酸ナトリウムと無水炭酸
カリウムで乾燥した。ろ過後、アセトニトリルを減圧下
留去することにより、5−アミノ−3−クロロ−1−メ
チルピラゾールが白色結晶として35g(収率91%)
得られた。融点 84.0〜85.0℃
Next, 100 ml of hydrochloric acid (31%) and 50 ml of water
The above crystals were added little by little while the mixed aqueous solution of was heated and stirred at 80 ° C. (Evolution of carbon dioxide was observed.) After the addition of crystals was completed, stirring was further carried out at 80 ° C. for 3 hours. Then, under reduced pressure, about half of the water was distilled off, and then an aqueous potassium hydroxide solution was added to make the solution alkaline to a pH of about 11. Further, 300 ml of acetonitrile was added to a portion where water was completely distilled off under reduced pressure, followed by drying with anhydrous sodium sulfate and anhydrous potassium carbonate. After filtration, acetonitrile was distilled off under reduced pressure to obtain 35 g of 5-amino-3-chloro-1-methylpyrazole as white crystals (yield 91%).
Was obtained. Melting point 84.0-85.0 ° C

【0084】 3−クロロ−1−メチル−5−(2−
ピリミジルアミノ)ピラゾールの合成 5−アミノ−3−クロロ−1−メチルピラゾール52g
にぎ酸27.3gを加え、続いて無水酢酸50.4gを
滴下して加えた。室温で2日間攪拌した。減圧下、溶媒
を留去した。クロロホルム160mlを加え無水硫酸ナト
リウムで乾燥した。ろ過後、溶媒を留去することによ
り、N−(3−クロロ−1−メチル−5−ピラゾリル)
ホルムアミド約68gを得た。これを精製することなく
次の反応に使用した。水素化ナトリウム(55%油状)
21gの懸濁したN,N−ジメチルホルムアミド400
mlの溶液に氷冷下、上記のN−(3−クロロ−1−メチ
ル−5−ピラゾリル)ホルムアミド68gとN,N−ジ
メチルホルムアミド120mlの混合物を滴下して加え
た。室温で4時間攪拌後、2−クロロピリミジン49.
9gを加えた。その後室温で2時間、120℃で15時
間攪拌した。冷却後、溶媒を減圧下で留去し、クロロホ
ルム200mlと水を200mlを加え、室温で2時間攪拌
した。クロロホルム抽出し、水洗後、無水硫酸ナトリウ
ムで乾燥した。ろ過後、溶媒を減圧下留去すると、褐色
の結晶物が得られた。そこにエタノール100mlとジエ
チルエーテル100mlを加え攪拌した後、結晶をろ過
し、エタノールで洗浄後、乾燥することにより3−クロ
ロ−1−メチル−5−(2−ピリミジルアミノ)ピラゾ
ールが43g(収率52%)得られた。融点 146.
0〜148.0℃
3-chloro-1-methyl-5- (2-
Synthesis of pyrimidylamino) pyrazole 5-amino-3-chloro-1-methylpyrazole 52 g
27.3 g of formic acid was added, followed by dropwise addition of 50.4 g of acetic anhydride. It was stirred at room temperature for 2 days. The solvent was distilled off under reduced pressure. Chloroform (160 ml) was added and the mixture was dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off to give N- (3-chloro-1-methyl-5-pyrazolyl).
About 68 g of formamide was obtained. This was used in the next reaction without purification. Sodium hydride (55% oily)
21 g of suspended N, N-dimethylformamide 400
A mixture of 68 g of the above N- (3-chloro-1-methyl-5-pyrazolyl) formamide and 120 ml of N, N-dimethylformamide was added dropwise to the ml solution under ice cooling. After stirring at room temperature for 4 hours, 2-chloropyrimidine 49.
9 g was added. Then, the mixture was stirred at room temperature for 2 hours and at 120 ° C. for 15 hours. After cooling, the solvent was distilled off under reduced pressure, 200 ml of chloroform and 200 ml of water were added, and the mixture was stirred at room temperature for 2 hours. It was extracted with chloroform, washed with water, and dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off under reduced pressure to obtain a brown crystalline substance. After 100 ml of ethanol and 100 ml of diethyl ether were added thereto and stirred, the crystals were filtered, washed with ethanol and dried to give 43 g of 3-chloro-1-methyl-5- (2-pyrimidylamino) pyrazole (yield 52 %) Obtained. Melting point 146.
0-148.0 ° C

【0085】 3−クロロ−4−(3−フルオロ−4
−メチルフェニルチオ)−1−メチル−5−(2−ピリ
ミジルアミノ)ピラゾールの合成(本発明化合物No.
168の合成) 3−クロロ−1−メチル−5−(2−ピリミジルアミ
ノ)ピラゾール16.6gを無水クロロホルム150ml
に溶解し、氷水で約10℃位に冷却した。そこに、3−
フルオロ−4−メチルフェニルスルフェニルクロライド
16.1gとクロロホルム10mlの混合液を滴下して加
えた。終了後、室温で6時間攪拌した。飽和炭酸ナトリ
ウム水溶液を50ml加え、さらに30分間攪拌した。ク
ロロホルム抽出し、水洗後、無水硫酸ナトリウムで乾燥
した。ろ過後、クロロホルムを減圧下留去すると結晶が
得られた。そこにジエチルエーテル50mlとエタノール
50mlを加え攪拌した後、結晶をろ別しエタノールで洗
浄した。結晶を乾燥することにより、淡灰色の結晶とし
て3−クロロ−4−(3−フルオロ−4−メチルフェニ
ルチオ)−1−メチル−5−(2−ピリミジルアミノ)
ピラゾールが21.5g(収率77%)得られた。融点
178.0〜179.0℃
3-chloro-4- (3-fluoro-4)
-Methylphenylthio) -1-methyl-5- (2-pyrimidylamino) pyrazole (present compound No.
Synthesis of 168) 16.6 g of 3-chloro-1-methyl-5- (2-pyrimidylamino) pyrazole was added to 150 ml of anhydrous chloroform.
And was cooled to about 10 ° C. with ice water. There, 3-
A mixed solution of 16.1 g of fluoro-4-methylphenylsulfenyl chloride and 10 ml of chloroform was added dropwise. After the completion, the mixture was stirred at room temperature for 6 hours. 50 ml of saturated sodium carbonate aqueous solution was added, and the mixture was further stirred for 30 minutes. It was extracted with chloroform, washed with water, and dried over anhydrous sodium sulfate. After filtration, chloroform was distilled off under reduced pressure to obtain crystals. 50 ml of diethyl ether and 50 ml of ethanol were added thereto, and the mixture was stirred, then the crystals were separated by filtration and washed with ethanol. The crystals were dried to give 3-chloro-4- (3-fluoro-4-methylphenylthio) -1-methyl-5- (2-pyrimidylamino) as light gray crystals.
21.5 g (yield 77%) of pyrazole was obtained. Melting point 178.0-179.0 ° C

【0086】〔製造例6〕 N−(3−クロロ−4−(3−フルオロ−4−メチルフ
ェニルチオ)−1−メチル−5−ピラゾリル)−N−
(2−ピリミジル)ホルムアミドの合成(本発明化合物
No.189の合成) 3−クロロ−4−(3−フルオロ−4−メチルフェニル
チオ)−1−メチル−5−(2−ピリミジルアミノ)ピ
ラゾール25.0gに、ぎ酸13.5gと無水酢酸3
0.4gを加え、室温で14時間攪拌した。均一になっ
た反応液の溶媒を減圧留去した後、クロロホルム100
mlと水100mlを加え1時間攪拌した。クロロホルム層
を抽出、さらに水洗いし無水硫酸ナトリウムで乾燥し
た。ろ過後、クロロホルムを減圧留去し、ジイソプロピ
ルエーテルを2ml加え結晶を析出させ、ノルマルヘキサ
ン40mlで洗浄、ろ過した。さらにノルマルヘキサン4
0mlとジイソプロピルエーテル7mlの混合液で洗浄し
た。これを乾燥させることで白色結晶として、N−(3
−クロロ−4−(3−フルオロ−4−メチルフェニルチ
オ)−1−メチル−5−ピラゾリル)−N−(2−ピリ
ミジル)ホルムアミドが23.9g(収率88%)得ら
れた。融点91.0〜92.0℃
Production Example 6 N- (3-chloro-4- (3-fluoro-4-methylphenylthio) -1-methyl-5-pyrazolyl) -N-
Synthesis of (2-pyrimidyl) formamide (Synthesis of compound No. 189 of the present invention) 3-chloro-4- (3-fluoro-4-methylphenylthio) -1-methyl-5- (2-pyrimidylamino) pyrazole 25. 0 g, formic acid 13.5 g and acetic anhydride 3
0.4 g was added, and the mixture was stirred at room temperature for 14 hours. After distilling off the solvent of the homogenized reaction solution under reduced pressure, chloroform 100
ml and 100 ml of water were added and stirred for 1 hour. The chloroform layer was extracted, washed with water, and dried over anhydrous sodium sulfate. After filtration, chloroform was distilled off under reduced pressure, 2 ml of diisopropyl ether was added to precipitate crystals, and the crystals were washed with 40 ml of normal hexane and filtered. Normal n-hexane 4
It was washed with a mixed solution of 0 ml and 7 ml of diisopropyl ether. By drying this, N- (3
23.9 g (yield 88%) of -chloro-4- (3-fluoro-4-methylphenylthio) -1-methyl-5-pyrazolyl) -N- (2-pyrimidyl) formamide were obtained. Melting point 91.0-92.0 ° C

【0087】〔製造例7〕(本発明化合物No.278
の合成) 1,3−ジメチル−5−(6−フルオロ−2−ピリ
ジルアミノ)ピラゾールの合成 水素化ナトリウム(55% 油状)1.5gの懸濁した
N,N−ジメチルホルムアミド100mlの溶液に、N−
(1,3−ジメチル−5−ピラゾリル)ホルムアミド4
gとN,N−ジメチルホルムアミド15mlの混合液を冷
却下滴下して加えた。滴下終了後、室温で4時間攪拌し
た。2,6−ジフルオロピリジンを3.2g加え、室温
で18時間、130℃で3時間攪拌した。冷却後、減圧
下溶媒を留去し、残渣をクロロホルム抽出し、水洗後、
無水硫酸ナトリウムで乾燥した。ろ過後、溶媒を留去
し、残渣をシリカゲルカラムクロマトグラフィー(展開
液;クロロホルム)で精製することにより、1,3−ジ
メチル−5−(6−フルオロ−2−ピリジルアミノ)ピ
ラソールが3.6g(収率65%)得られた。融点11
2.0〜113.0℃
[Production Example 7] (Compound No. 278 of the present invention)
Synthesis of 1,3-dimethyl-5- (6-fluoro-2-pyridylamino) pyrazole To a solution of 1.5 g of suspended sodium hydride (55% oily) in N, N-dimethylformamide was added N. −
(1,3-Dimethyl-5-pyrazolyl) formamide 4
A mixed solution of g and 15 ml of N, N-dimethylformamide was added dropwise under cooling. After completion of dropping, the mixture was stirred at room temperature for 4 hours. 3.2 g of 2,6-difluoropyridine was added, and the mixture was stirred at room temperature for 18 hours and at 130 ° C. for 3 hours. After cooling, the solvent was distilled off under reduced pressure, the residue was extracted with chloroform, washed with water,
It was dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off, and the residue was purified by silica gel column chromatography (developing solution; chloroform) to give 3.6 g of 1,3-dimethyl-5- (6-fluoro-2-pyridylamino) pyrazole. Yield 65%) was obtained. Melting point 11
2.0-113.0 ° C

【0088】 1,3−ジメチル−4−(3−フルオ
ロ−4−メチルフェニルチオ)−5−(6−フルオロ−
2−ピリジルアミノ)ピラゾールの合成(本発明化合物
No.278の合成) 1,3−ジメチル−5−(6−フルオロ−2−ピリジル
アミノ)ピラゾール0.6gを無水クロロホルム30ml
に溶解し、3−フルオロ−4−メチルフェニルスルフェ
ニルクロライド0.61gを加え、室温で12時間攪拌
した。飽和炭酸ナトリウム水溶液を10ml加え30分間
攪拌した。クロロホルム抽出し、水洗後、無水硫酸ナト
リウムで乾燥した。ろ過後、溶媒を減圧下留去し、残っ
た結晶をジイソプロピルエーテルで洗浄することによ
り、1,3−ジメチル−4−(3−フルオロ−4−メチ
ルフェニルチオ)−5−(6−フルオロ−2−ピリジル
アミノ)ピラゾールが0.72g(収率71%)得られ
た。融点 96.0〜98.0℃
1,3-dimethyl-4- (3-fluoro-4-methylphenylthio) -5- (6-fluoro-
Synthesis of 2-pyridylamino) pyrazole (Synthesis of compound No. 278 of the present invention) 0.6 g of 1,3-dimethyl-5- (6-fluoro-2-pyridylamino) pyrazole was added to 30 ml of anhydrous chloroform.
Was dissolved in the solution, 0.61 g of 3-fluoro-4-methylphenylsulfenyl chloride was added, and the mixture was stirred at room temperature for 12 hours. 10 ml of saturated sodium carbonate aqueous solution was added and stirred for 30 minutes. It was extracted with chloroform, washed with water, and dried over anhydrous sodium sulfate. After filtration, the solvent was evaporated under reduced pressure, and the remaining crystals were washed with diisopropyl ether to give 1,3-dimethyl-4- (3-fluoro-4-methylphenylthio) -5- (6-fluoro- 0.72 g (yield 71%) of 2-pyridylamino) pyrazole was obtained. Melting point 96.0-98.0 ° C

【0089】〔製造例8〕(本発明化合物No.9の合
成) 5−アミノ−3−メトキシ−1−メチルピラゾール
の合成 5−アミノ−3−メトキシ−1−メチル−4−メトキシ
カルボニルピラゾール10.5gを水酸化ナトリウム
6.1gを溶解したメタノール150mlと水150mlの
水溶液に加え、過熱還流を3時間行った。冷却した後、
溶媒を減圧下留去し、氷冷下、塩酸を加えpH2の酸性
とした。減圧下、水を完全に留去した後、エタノール1
50mlを加え、無水硫酸ナトリウムで乾燥した。ろ過
後、エタノールを留去すると、淡黄色の油状が残った。
キシレン100mlと銅粉0.5gを加えて加熱還流を1
8時間行った。銅粉をろ過して除きキシレンを減圧留去
した後、アセトニトリル100mlを加え無水硫酸ナトリ
ウムで乾燥した。ろ過後、減圧下溶媒を留去することに
より、5−アミノ−3−メトキシ−1−メチルピラゾー
ルが6.67g(収率92%)得られた。
[Production Example 8] (Synthesis of Compound No. 9 of the Invention) Synthesis of 5-amino-3-methoxy-1-methylpyrazole 5-Amino-3-methoxy-1-methyl-4-methoxycarbonylpyrazole 10 0.5 g was added to an aqueous solution of 150 ml of methanol and 150 ml of water in which 6.1 g of sodium hydroxide was dissolved, and the mixture was heated and refluxed for 3 hours. After cooling
The solvent was distilled off under reduced pressure, and hydrochloric acid was added to make the solution acidic with pH 2 under ice cooling. After completely distilling off the water under reduced pressure, ethanol 1
50 ml was added and dried over anhydrous sodium sulfate. After filtration, the ethanol was distilled off, leaving a pale yellow oil.
Add 100 ml of xylene and 0.5 g of copper powder and heat to reflux 1
It went for 8 hours. After the copper powder was removed by filtration and xylene was distilled off under reduced pressure, 100 ml of acetonitrile was added and the mixture was dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off under reduced pressure to obtain 6.67 g (yield 92%) of 5-amino-3-methoxy-1-methylpyrazole.

【0090】 3−メトキシ−1−メチル−5−(2
−ピリミジルアミノ)ピラゾールの合成 5−アミノ−3−メトキシ−1−メチルピラゾール6.
67gに、ぎ酸6.6gを加え、続いて無水酢酸を1
6.2g滴下して加え、室温で3日間攪拌した。減圧下
溶媒を留去し、クロロホルムを100ml加え無水硫酸ナ
トリウムで乾燥した。ろ過後減圧濃縮すると、N−(3
−メトキシ−1−メチル−5−ピラゾリル)ホルムアミ
ドの粗製物が9.7g得られた。精製することなく次の
反応を行った。水素化ナトリウム(55% 油状)3.
3gを懸濁させたN,N−ジメチルホルムアミド150
mlに上記のN−(3−メトキシ−1−メチル−5−ピラ
ゾリル)ホルムアミド9.7gとN,N−ジメチルホル
ムアミド50mlの混合液を滴下して加え室温で4時間攪
拌した。続いて2−クロロピリミジン7.9gを加え、
100℃で18時間攪拌した。冷却後、減圧濃縮した残
渣をクロロホルム抽出し、水洗後、無水硫酸ナトリウム
で乾燥した。ろ過後、溶媒を留去し、残渣をシリカゲル
カラムクロマトグラフィー(展開液;クロロホルム)で
精製することにより、油状物質として3−メトキシ−1
−メチル−5−(2−ピリミジルアミノ)ピラゾールが
2.6g(収率24%)得られた。
3-methoxy-1-methyl-5- (2
Synthesis of 5-pyrimidylamino) pyrazole 5-amino-3-methoxy-1-methylpyrazole 6.
To 67 g, add 6.6 g of formic acid, followed by 1 part of acetic anhydride.
6.2 g was added dropwise, and the mixture was stirred at room temperature for 3 days. The solvent was distilled off under reduced pressure, 100 ml of chloroform was added, and the mixture was dried over anhydrous sodium sulfate. After filtration and concentration under reduced pressure, N- (3
9.7 g of crude product of -methoxy-1-methyl-5-pyrazolyl) formamide was obtained. The next reaction was carried out without purification. Sodium hydride (55% oil) 3.
N, N-dimethylformamide 150 in which 3 g was suspended
A mixed solution of 9.7 g of N- (3-methoxy-1-methyl-5-pyrazolyl) formamide and 50 ml of N, N-dimethylformamide was added dropwise to ml, and the mixture was stirred at room temperature for 4 hours. Then add 7.9 g of 2-chloropyrimidine,
The mixture was stirred at 100 ° C for 18 hours. After cooling, the residue concentrated under reduced pressure was extracted with chloroform, washed with water, and dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off, and the residue was purified by silica gel column chromatography (developing solution; chloroform) to give 3-methoxy-1 as an oily substance.
2.6 g (24% yield) of -methyl-5- (2-pyrimidylamino) pyrazole were obtained.

【0091】 4−(3−クロロ−4−メチルフェニ
ルチオ)−3−メトキシ−1−メチル−5−(2−ピリ
ミジルアミノ)ピラゾールの合成(本発明化合物No.
9の合成) 3−メトキシ−1−メチル−5−(2−ピリミジルアミ
ノ)ピラゾール0.7gを無水クロロホルム30mlに溶
解し、3−クロロ−4−メチルフェニルスルフェニルク
ロライド0.65gを加え、室温で18時間攪拌した。
飽和炭酸ナトリウム水溶液を加え室温で30分間攪拌
後、クロロホルム抽出し、水洗後、無水硫酸ナトリウム
で乾燥した。ろ過後、溶媒を留去し、残渣をシリカゲル
カラムクロマトグラフィー(展開液;クロロホルム)で
精製することにより、4−(3−クロロ−4−メチルフ
ェニルチオ)−3−メトキシ−1−メチル−5−(2−
ピリミジルアミノ)ピラゾールが0.57g(収率51
%)得られた。融点 148.0〜150.0℃ これらの方法に準じて製造した化合物の物性を第2表に
示す。
Synthesis of 4- (3-chloro-4-methylphenylthio) -3-methoxy-1-methyl-5- (2-pyrimidylamino) pyrazole (Compound No. of the present invention)
Synthesis of 9) 0.7 g of 3-methoxy-1-methyl-5- (2-pyrimidylamino) pyrazole was dissolved in 30 ml of anhydrous chloroform, 0.65 g of 3-chloro-4-methylphenylsulfenyl chloride was added, and the mixture was stirred at room temperature. Stir for 18 hours.
A saturated aqueous sodium carbonate solution was added, and the mixture was stirred at room temperature for 30 minutes, extracted with chloroform, washed with water, and dried over anhydrous sodium sulfate. After filtration, the solvent was distilled off, and the residue was purified by silica gel column chromatography (developing solution; chloroform) to give 4- (3-chloro-4-methylphenylthio) -3-methoxy-1-methyl-5. -(2-
0.57 g of pyrimidylamino) pyrazole (yield 51
%) Obtained. Melting point 148.0 to 150.0 ° C. Table 2 shows the physical properties of the compounds produced according to these methods.

【0092】第 2 表Table 2

【0093】[0093]

【表14】 ────────────────────────────── 化合物 1H-NMR No. 物 性 δ(ppm, CDCl3 )、標準物質TMS ────────────────────────────── 1 m.p. 168.0〜169.0 ℃ 2 m.p. 175.0〜176.0 ℃ 3 m.p. 162.0〜163.0 ℃ 4 m.p. 91.0〜 93.0 ℃ 5 m.p. 184.0〜185.0 ℃ 6 m.p. 172.0〜174.0 ℃ 7 m.p. 179.0〜181.0 ℃ 9 m.p. 148.0〜150.0 ℃ 10 m.p. 209.0〜210.0 ℃ 11 m.p. 137.0〜138.0 ℃ 12 m.p. 153.0〜155.0 ℃ 15 m.p. 209.0〜212.0 ℃ 16 m.p. 168.0〜170.0 ℃ 17 m.p. 92.0〜 95.0 ℃ 18 m.p. 136.0〜138.0 ℃ 19 m.p. 120.0〜124.0 ℃ 20 m.p. 177.0〜180.0 ℃ 21 m.p. 157.0〜159.0 ℃ 22 m.p. 147.0〜148.0 ℃ 95 m.p. 80.0〜 82.0 ℃ 96 m.p. 88.0〜 89.0 ℃ ──────────────────────────────[Table 14] ────────────────────────────── Compound 1 H-NMR No. Physical property δ (ppm, CDCl 3 ) , Reference material TMS ────────────────────────────── 1 mp 168.0 to 169.0 ℃ 2 mp 175.0 to 176.0 ℃ 3 mp 162.0 to 163.0 ℃ 4 mp 91.0-93.0 ℃ 5 mp 184.0-185.0 ℃ 6 mp 172.0-174.0 ℃ 7 mp 179.0-181.0 ℃ 9 mp 148.0-150.0 ℃ 10 mp 209.0-210.0 ℃ 11 mp 137.0-138.0 ℃ 12 mp 153.0-155.0 ℃ 15 mp 209.0 to 212.0 ℃ 16 mp 168.0 to 170.0 ℃ 17 mp 92.0 to 95.0 ℃ 18 mp 136.0 to 138.0 ℃ 19 mp 120.0 to 124.0 ℃ 20 mp 177.0 to 180.0 ℃ 21 mp 157.0 to 159.0 ℃ 22 mp 147.0 to 148.0 ℃ 95 mp 80.0 to 82.0 ℃ 96 mp 88.0 to 89.0 ℃ ───────────────────────────────

【0094】[0094]

【表15】 第 2 表 (続き) ────────────────────────────── 化合物 1H-NMR No. 物 性 δ(ppm, CDCl3 )、標準物質TMS ────────────────────────────── 99 m.p. 90.0〜 91.0 ℃ 100 m.p. 142.0〜145.0 ℃ 104 樹脂状 2.20(s,6H), 3.55(s,3H), 5.10(bs,1H), 6.05(s,1H),6.50〜7.60(m,6H), 8.40(d,1H,J=5Hz) 105 油状物 2.17(s,3H), 3.30(s,3H), 3.68(s,3H), 5.68(s,1H),6.80〜7.70(m,7H), 8.30〜8.50(m,1H) 107 油状物 2.10(s,3H), 2.25(s,3H), 4.05(s,3H), 6.80〜8.70(m,9H) 111 油状物 2.19(s,3H), 3.77(s,3H), 6.67(d,1H,J=45Hz) 6.90〜7.70(m,7H), 8.51(d,1H,J=5Hz) 115 m.p. 111.0〜113.0 ℃ 119 油状物 2.03(s,3H), 2.16(s,3H), 3.69(s,3H), 6.00(bs,1H), 6.80〜8.51(m,8H) 127 樹脂状 0.50(d,3H,J=7Hz), 1.00(d,3H,J=7Hz), 2.02(s,3H),3.21〜3.65(m,1H), 3.87(s,3H), 6.00(bs,3H), 6.61〜8.35(m,8H) 131 油状物 1.71(d,3H,J=7Hz), 2.17(s,3H), 3.73(s,3H), 4.69(q,1H,J=7Hz),6.70〜7.60(m,7Hz), 8.30〜8.50(m,1H) ──────────────────────────────[Table 15] Table 2 (continued) ────────────────────────────── Compound 1 H-NMR No. Physical property δ (ppm, CDCl 3 ), reference material TMS ────────────────────────────── 99 mp 90.0 to 91.0 ℃ 100 mp 142.0 to 145.0 ℃ 104 Resin 2.20 (s, 6H), 3.55 (s, 3H), 5.10 (bs, 1H), 6.05 (s, 1H), 6.50 ~ 7.60 (m, 6H), 8.40 (d, 1H, J = 5Hz) 105 Oil 2.17 (s, 3H), 3.30 (s, 3H), 3.68 (s, 3H), 5.68 (s, 1H), 6.80 ~ 7.70 (m, 7H), 8.30 ~ 8.50 (m, 1H) 107 oil 2.10 (s, 3H), 2.25 (s, 3H), 4.05 (s, 3H), 6.80-8.70 (m, 9H) 111 oil 2.19 (s, 3H), 3.77 (s, 3H), 6.67 (d, 1H, J = 45Hz) 6.90 to 7.70 (m, 7H), 8.51 (d, 1H, J = 5Hz) 115 mp 111.0 to 113.0 ° C 119 oil 2.03 (s, 3H), 2.16 (s, 3H) , 3.69 (s, 3H), 6.00 (bs, 1H), 6.80 ~ 8.51 (m, 8H) 127 Resinous 0.50 (d, 3H, J = 7Hz), 1.00 (d, 3H, J = 7Hz), 2.02 ( s, 3H), 3.21 to 3.65 (m, 1H), 3.87 (s, 3H), 6.00 (bs, 3H), 6.61 to 8.35 (m, 8H) 131 oil 1.71 (d, 3H, J = 7Hz), 2.17 (s, 3H), 3.73 (s, 3H), 4.69 (q, 1H, J = 7Hz), 6.70 ~ 7.60 (m, 7Hz), 8.30 ~ 8.50 (m , 1H) ───────────────────────────────

【0095】[0095]

【表16】 第 2 表 (続き) ────────────────────────────── 化合物 1H-NMR No. 物 性 δ(ppm, CDCl3 )、標準物質TMS ────────────────────────────── 145 m.p. 218.0〜220.0 ℃ 155 m.p. 121.0〜122.0 ℃ 167 m.p. 174.0〜175.0 ℃ 168 m.p. 178.0〜179.0 ℃ 169 m.p. 157.0〜159.0 ℃ 170 m.p. 156.0〜157.0 ℃ 171 m.p. 159.0〜160.0 ℃ 172 m.p. 184.0〜186.0 ℃ 173 m.p. 179.0〜180.0 ℃ 174 m.p. 186.0〜187.0 ℃ 175 m.p. 172.0〜173.0 ℃ 176 m.p. 172.0〜174.0 ℃ 177 m.p. 154.0〜155.0 ℃ 178 m.p. 136.0〜139.0 ℃ 179 m.p. 167.0〜168.0 ℃ 180 m.p. 144.0〜145.0 ℃ 181 m.p. 132.0〜133.0 ℃ 182 m.p. 144.0〜145.0 ℃ 183 m.p. 132.0〜133.0 ℃ 184 m.p. 149.0〜150.0 ℃ 185 m.p. 143.0〜144.0 ℃ ──────────────────────────────[Table 16] Table 2 (continued) ────────────────────────────── Compound 1 H-NMR No. Physical Properties δ (ppm, CDCl 3 ), reference material TMS ────────────────────────────── 145 mp 218.0-220.0 ℃ 155 mp 121.0- 122.0 ℃ 167 mp 174.0 to 175.0 ℃ 168 mp 178.0 to 179.0 ℃ 169 mp 157.0 to 159.0 ℃ 170 mp 156.0 to 157.0 ℃ 171 mp 159.0 to 160.0 ℃ 172 mp 184.0 to 186.0 ℃ 173 mp 179.0 to 180.0 ℃ 174 mp 186.0 to 187.0 175 mp 172.0 to 173.0 ° C 176 mp 172.0 to 174.0 ° C 177 mp 154.0 to 155.0 ° C 178 mp 136.0 to 139.0 ° C 179 mp 167.0 to 168.0 ° C 180 mp 144.0 to 145.0 ° C 181 mp 132.0 to 133.0 ° C 182 mp 144.0 to 145.0 ° C 132.0-133.0 ℃ 184 mp 149.0-150.0 ℃ 185 mp 143.0-144.0 ℃ ─────────────────── ─────────────

【0096】[0096]

【表17】 第 2 表 (続き) ─────────────────────────────── 化合物 1H-NMR No. 物 性 δ(ppm, CDCl3 )、標準物質TMS ─────────────────────────────── 186 m.p. 140.0〜141.0 ℃ 187 m.p. 90.0〜 91.0 ℃ 188 油状物 189 m.p. 91.0〜 92.0 ℃ 190 樹脂状 191 油状物 263 m.p. 153.0〜154.0 ℃ 264 m.p. 117.0〜119.0 ℃ 265 m.p. 108.0〜110.0 ℃ 266 m.p. 116.0〜118.0 ℃ 270 油状物 271 m.p. 183.0〜184.0 ℃ 275 m.p. 172.0〜174.0 ℃ 276 m.p. 104.0〜106.0 ℃ 277 m.p. 142.0〜144.0 ℃ 278 m.p. 96.0〜 98.0 ℃ ─────────────────────────────── 本発明化合物を農園芸用殺菌剤として使用するにあたっ
ては、一般には適当な担体、例えばクレー、タルク、ベ
ントナント、珪藻土等の固体担体あるいは水、アルコー
ル類(メタノール、エタノール等)、芳香族炭化水素類
(ベンゼン、トルエン、キシレン等)、塩素化炭化水素
類、エーテル類、ケトン類、エステル類(酢酸エチル
等)、酸アミド類(ジメチルホルムアミド等)などの液
体担体と混用して適用することができ、所望により乳化
剤、分散剤、懸濁剤、浸透剤、展着剤、安定剤などを添
加し、液剤、油剤、乳剤、水和剤、粉剤、粒剤、フロア
ブル剤等任意の剤型にて実用に供することができる。
[Table 17] Table 2 (continued) ─────────────────────────────── Compound 1 H-NMR No. Physical Properties δ (ppm, CDCl 3 ), reference material TMS ─────────────────────────────── 186 mp 140.0-141.0 ℃ 187 mp 90.0 to 91.0 ° C. 188 oil 189 mp 91.0 to 92.0 ° C. 190 resinous 191 oil 263 mp 153.0 to 154.0 ° C. 264 mp 117.0 to 119.0 ° C. 265 mp 108.0 to 110.0 ° C. 266 mp 116.0 to 118.0 ° C. 270 oily substance 271 mp 183.0 to 184.0 ℃ 275 mp 172.0 to 174.0 ℃ 276 mp 104.0 to 106.0 ℃ 277 mp 142.0 to 144.0 ℃ 278 mp 96.0 to 98.0 ℃ ──────────────────────── In using the compound of the present invention as an agricultural and horticultural fungicide, generally, a suitable carrier such as clay, talc, vent is used. Solid carriers such as Nantes and diatomaceous earth or water, alcohols (methanol, ethanol, etc.), aromatic hydrocarbons (benzene, toluene, xylene, etc.), chlorinated hydrocarbons, ethers, ketones, esters (ethyl acetate) Etc.), acid amides (dimethylformamide, etc.) and the like can be mixed and applied with a liquid carrier, and if desired, an emulsifier, a dispersant, a suspending agent, a penetrant, a spreading agent, a stabilizer, etc. are added, It can be put into practical use in any dosage form such as a liquid preparation, an oil preparation, an emulsion, a wettable powder, a powder preparation, a granule preparation and a flowable preparation.

【0097】また、必要に応じて製剤または散布時に他
種の除草剤、各種殺虫剤、殺菌剤、植物生長調節剤、共
力剤などと混合施用してもよい。本発明化合物の施用薬
量は適用場面、施用時期、施用方法、対象病害、栽培作
物等により差異はあるが一般には有効成分量としてヘク
タール当たり0.005 〜50kg程度が適当である。次に、本
発明化合物を有効成分とする殺菌剤の製剤例を示すがこ
れらのみに限定されるものではない。なお、以下の製剤
例において「部」は重量部を意味する。
If necessary, other herbicides, various insecticides, fungicides, plant growth regulators, synergists and the like may be mixed and applied during preparation or spraying. The application dose of the compound of the present invention varies depending on the application scene, application time, application method, target disease, cultivated crop and the like, but generally, an effective amount of about 0.005 to 50 kg per hectare is suitable. Next, formulation examples of bactericides containing the compound of the present invention as an active ingredient will be shown, but the formulations are not limited thereto. In addition, in the following formulation examples, "part" means part by weight.

【0098】製剤例1 乳 剤 本発明化合物 -------- 20 部 キシレン -------- 55 部 N,N−ジメチルホルムアミド ------- 20 部 ソルポール2680 --------- 5 部 (非イオン性界面活性剤とアニオン性界面活性剤との混
合物:東邦化学工業(株)商品名) 以上を均一に混合して乳剤とする。使用に際しては上記
乳剤を50〜 20000倍に希釈して有効成分量がヘクタール
当たり 0.005〜50kgになるように散布する。
Formulation Example 1 Emulsion Compound of the present invention -------- 20 parts Xylene -------- 55 parts N, N-Dimethylformamide ------- 20 parts Solpol 2680- -------- 5 parts (mixture of nonionic surfactant and anionic surfactant: trade name of Toho Chemical Industry Co., Ltd.) The above components are uniformly mixed to form an emulsion. For use, the emulsion is diluted 50 to 20000 times and sprayed so that the amount of active ingredient is 0.005 to 50 kg per hectare.

【0099】製剤例2 水和剤 本発明化合物 -------- 25 部 ジークライトPFP -------- 66 部 (カオリナイトとセリサイトの混合物;ジークライト工
業(株)商品名) ソルポール5039 ------- 4 部 (アニオン性界面活性剤:東邦化学工業(株)商品名) カープレックス#80 ------- 3 部 (ホワイトカーボン:塩野義製薬(株)商品名) リグニンスルホン酸カルシウム------- 2 部 以上を均一に混合粉砕して水和剤とする。使用に際して
は上記水和剤を50〜 20000倍に希釈して有効成分量がヘ
クタール当たり 0.005〜50kgになるように散布する。
Formulation Example 2 Wettable powder Compound of the present invention -------- 25 parts Diclite PFP -------- 66 parts (mixture of kaolinite and sericite; Siglite Industrial Co., Ltd.) Product name: Solpol 5039 ------- 4 parts (Anionic surfactant: Toho Chemical Industry Co., Ltd. product name) Carplex # 80 ------- 3 parts (White carbon: Shionogi & Co. Brand name Calcium lignin sulfonate ------- 2 parts or more are uniformly mixed and pulverized to obtain a wettable powder. Before use, dilute the wettable powder 50 to 20000 times and spray it so that the amount of the active ingredient is 0.005 to 50 kg per hectare.

【0100】製剤例3 油 剤 本発明化合物 -------- 10 部 メチルセルソルブ -------- 90 部 以上を均一に混合して油剤とする。使用に際して上記油
剤を有効成分量がヘクタール当たり 0.005〜50kgになる
ように散布する。
Formulation Example 3 Oil agent Compound of the present invention --- 10 parts Methylcellosolve -------- 90 parts The above ingredients are uniformly mixed to obtain an oil agent. At the time of use, the above oil agent is sprinkled so that the amount of the active ingredient is 0.005 to 50 kg per hectare.

【0101】製剤例4 粉 剤 本発明化合物 ------- 3.0部 カープレックス#80 ------- 0.5部 (ホワイトカーボン:塩野義製薬(株)商品名) クレー ------- 95 部 リン酸ジイソプロピル ------- 1.5部 以上を均一に混合粉砕して粉剤とする。使用に際して上
記粉剤を有効成分量がヘクタール当たり 0.005〜50kgに
なるように散布する。
Formulation Example 4 Powder Compound of the present invention ------- 3.0 parts Carplex # 80 ------- 0.5 part (white carbon: Shionogi Pharmaceutical Co., Ltd. trade name) Clay --- ---- 95 parts Diisopropyl phosphate ------- 1.5 parts The above is mixed and pulverized uniformly to give a powder. Before use, spray the above powder so that the amount of active ingredient is 0.005 to 50 kg per hectare.

【0102】製剤例5 粒 剤 本発明化合物 ------- 5 部 ベントナイト ------- 54 部 タルク ------- 40 部 リグニンスルホン酸カルシウム------- 1 部 以上を均一に混合粉砕して少量の水を加えて撹拌混合
し、押出式造粒機で造粒し、乾燥して粒剤とする。使用
に際して上記粒剤を有効成分量がヘクタール当たり 0.0
05〜50kgになるように散布する。
Formulation Example 5 Granules Compound of the present invention ------- 5 parts Bentonite ------- 54 parts Talc ------- 40 parts Calcium lignin sulfonate --- -1 part or more is uniformly mixed and pulverized, a small amount of water is added, and the mixture is stirred and mixed, granulated by an extrusion granulator, and dried to obtain granules. When using the above granules, the amount of active ingredient is 0.0 per hectare.
Sprinkle so that it becomes 05 to 50 kg.

【0103】製剤例6 フロアブル剤 本発明化合物 ------- 25 部 ソルポール3353 ------- 10 部 (非イオン性界面活性剤:東邦化学工業(株)商品名) ルノックス1000C ------- 0.5 部 ( 陰イオン界面活性剤:東邦化学工業(株)商品名) 1%ザンサンガム水溶液 ------- 20 部 (天然高分子) 水 ------- 44.5部 有効成分(本発明化合物)を除く上記の成分を均一に溶
解し、ついで本発明化合物を加えよく撹拌した後,サン
ドミルにて湿式粉砕してフロアブル剤を得る。使用に際
しては、上記フロアブル剤を50〜 20000倍に希釈して有
効成分量がヘクタール当たり 0.005〜50kgになるように
散布する。
Formulation Example 6 Flowable agent Compound of the present invention ------- 25 parts Solpol 3353 ------- 10 parts (Nonionic surfactant: Toho Chemical Industry Co., Ltd. trade name) Lunox 1000C ------- 0.5 part (anionic surfactant: trade name of Toho Chemical Industry Co., Ltd.) 1% xanthan gum aqueous solution ------- 20 parts (natural polymer) water ------ -44.5 parts The above components except the active ingredient (the compound of the present invention) are uniformly dissolved, and then the compound of the present invention is added and well stirred, followed by wet grinding with a sand mill to obtain a flowable agent. Before use, dilute the flowable agent 50 to 20000 times and spray so that the amount of active ingredient is 0.005 to 50 kg per hectare.

【0104】次に、本発明化合物の対象となる植物病害
としては、イネのいもち病(Pyricularia oryzae) 、ご
ま葉枯病 (Cochliobolus miyabeanus)、紋枯病 (Rhizoc
tonia solani) 、ムギ類のうどんこ病 (Erysiphe gram
inis f.sp.hordei,f. sp.tritici) 、斑葉病 (Pyrenoph
ora graminea) 、網斑病(Pyrenophora teres) 、赤かび
病(Gibberella zeae)、さび病 (Puccinia striiformi
s, P.graminis, P.recondita, P.hordei)、雪腐病(Typh
ula sp.,Micronectriella nivais)、裸黒穂病 (Ustilag
o tritici,U.nuda)、アイスポット(Pseudocercosporell
a herpotrichoides) 、雲形病 (Rhynchosporium secali
s) 、葉枯病(Septoria tritici)、ふ枯病(Leptosphaeri
a nodorum)、
Next, the plant diseases targeted by the compounds of the present invention include rice blast (Pyricularia oryzae), sesame leaf blight (Cochliobolus miyabeanus), and blight (Rhizoc).
tonia solani), powdery mildew of wheat (Erysiphe gram)
inis f.sp.hordei, f.sp.tritici), leaf spot disease (Pyrenoph
ora graminea), net blotch (Pyrenophora teres), red mold (Gibberella zeae), rust (Puccinia striiformi)
s, P.graminis, P.recondita, P.hordei), snow rot (Typh
ula sp., Micronectriella nivais), bare smut (Ustilag
o tritici, U.nuda), eye spot (Pseudocercosporell
a herpotrichoides), cloud disease (Rhynchosporium secali
s), leaf blight (Septoria tritici), blight (Leptosphaeri)
a nodorum),

【0105】カンキツの黒点病 (Diaporthe citri)、そ
うか病(Elsinoe fawcetti)、果実腐敗病 (Penicillium
digitatum,P.italicum) 、リンゴのモニリア病 (Scler
otiniamali)、腐らん病 (Valsa mali) 、うどんこ病 (P
odosphaera leucotricha)、斑点落葉病 (Alternaria ma
li)、黒星病 (Venturia inaequalis) 、ナシの黒星病
(Venturia nashicola)、黒斑病 (Alternaria Kikuchia
na) 、赤星病(Gymnosporangium haraeanum) 、モモの灰
星病(Sclerotinia cinerea) 、黒星病(Cladosporium ca
rpophilum)、フォモプシス腐敗病(Phomopsis sp.) 、ブ
ドウのべと病(Plasmopara viticola) 、黒とう病 (Elsi
noe ampelina) 、晩腐病 (Glomerella cingulata) 、う
どんこ病(Uncinula necator)、さび病 (Phakopsora amp
elopsidis)、カキの炭そ病 (Gloeosporium kaki) 、落
葉病(Cercospora kaki, Mycosphaerella nawae) 、
Citrus black spot (Diapor the citri), scab (Elsinoe fawcetti), fruit rot (Penicillium)
digitatum, P.italicum), monili disease of apple (Scler
otiniamali), rot (Valsa mali), powdery mildew (P
odosphaera leucotricha), leaf spot disease (Alternaria ma
li), scab (Venturia inaequalis), pear scab
(Venturia nashicola), Black spot (Alternaria Kikuchia)
na), red scab (Gymnosporangium haraeanum), peach scab (Sclerotinia cinerea), scab (Cladosporium ca)
rpophilum), Phomopsis rot (Phomopsis sp.), downy mildew of grapes (Plasmopara viticola), black rot (Elsi
noe ampelina), late rot (Glomerella cingulata), powdery mildew (Uncinula necator), rust (Phakopsora amp)
elopsidis), oyster anthracnose (Gloeosporium kaki), leaf scab (Cercospora kaki, Mycosphaerella nawae),

【0106】ウリ類のべと病(Pseudoperenospora cuben
sis)、炭そ病 (Colletotrichum lagenarium)、うどんこ
病 (Sphaerotheca fuliginea) 、つる枯病(Mycosphaere
lla melonis) 、トマトの疫病(Phytophthora infesta
ns) 、輪紋病 (Alternaria solani)、葉かび病(Cladosp
orium fulvam) 、ナスの褐紋病 (Phomopsis vexans)、
うどんこ病 (Erysiphe cichoracoarum) 、アブラナ科野
菜の黒斑病 (Alternariajaponica)、白斑病(Cerocospor
ella brassicae)、ネギのさび病(Puccinia allii)、ダ
イズの紫斑病 (Cercospora kikuchii)、黒とう病 (Elsi
noe glycines) 、黒点病 (Diaporthe phaseololum)、イ
ンゲンの炭そ病 (Colletotrichum lindemuthianum)、ラ
ッカセイの黒渋病 (Mycosphaerella personatum)、褐斑
病(Cercospora arachidicola) 、エンドウのうどんこ病
(Erysiphe pisi)、
Downy mildew (Pseudoperenospora cuben) of cucumber
sis), anthracnose (Colletotrichum lagenarium), powdery mildew (Sphaerotheca fuliginea), vine blight (Mycosphaere)
lla melonis), a tomato plague (Phytophthora infesta)
ns), ring spot (Alternaria solani), leaf mold (Cladosp)
orium fulvam), brown leaf spot of eggplant (Phomopsis vexans),
Powdery mildew (Erysiphe cichoracoarum), Black spot (Alternaria japonica), White spot (Cerocospor) of cruciferous vegetables
ella brassicae), green onion rust (Puccinia allii), soybean purpura (Cercospora kikuchii), black spot (Elsi)
noe glycines), scab (Diaporthe phaseololum), kidney anthracnose (Colletotrichum lindemuthianum), peanut black astringent (Mycosphaerella personatum), brown spot (Cercospora arachidicola), and pea powdery mildew.
(Erysiphe pisi),

【0107】ジャガイモの夏疫病 (Alternaria solan
i)、イチゴのうどんこ病(Sphaerothecahumuli) 、チャ
の網もち病 (Exobasidium reticulatum)、白星病(Elsin
oe leucospila)、タバコの赤星病 (Alternaria longipe
s)、うどんこ病 (Erysiphe cichoracearum) 、炭そ病
(Colletotrichum tabacum) 、テンサイの褐斑病 (Cerco
spora beticola)、バラの黒星病 (Diplocarpon rosae)
、うどんこ病(Sphaerotheca pannosa)、キクの褐斑病
(Septoria chrysanthemiindici)、白さび病 (Puccinia
horiana) 、種々の作物の灰色かび病 (Botrytis cinere
a) 、菌核病 (Sclerotinia sclerotiorum) 等が挙げら
れる。本発明化合物の有用性について、以下の試験例に
おいて具体的に説明する。但し、これらのみに限定され
るものではない。
Summer blight of potato (Alternaria solan
i), strawberry powdery mildew (Sphaerothecahumuli), tea net blast (Exobasidium reticulatum), white scab (Elsin
oe leucospila), tobacco scab (Alternaria longipe)
s), powdery mildew (Erysiphe cichoracearum), anthracnose
(Colletotrichum tabacum), brown leaf spot of sugar beet (Cerco
spora beticola), rose scab (Diplocarpon rosae)
, Powdery mildew (Sphaerotheca pannosa), brown spot of chrysanthemum
(Septoria chrysanthemiindici), White rust (Puccinia
horiana), gray mold of various crops (Botrytis cinere
a), sclerotinia sclerotiorum, etc. The usefulness of the compound of the present invention will be specifically described in the following test examples. However, it is not limited to these.

【0108】試験例1 灰色かび病防除効果試験 直径7cmのポットで育成した1〜2葉期のキュウリ(品
種:相模半白)に、本発明化合物乳剤を水で希釈して5
00ppm に調製した薬液を、スプレーガンを用いポット
当たり20 ml 散布した。散布翌日薬液を散布したキュウ
リより葉を切取り、水を含ませた紙を敷いたバット内に
置いた。これにキュウリ灰色かび病菌(Botrytis ciner
ea) の胞子懸濁液(1.0 %グルコース、2.5 %酵母エキ
ス含有、×150・40個/視野)を噴霧接種した。接
種後、バットをビニールで覆い、温度18℃の恒温室に
5日間置いた。形成された病斑直径を測定し、下記の式
に従って、防除価を算出した。 防除価=〔1−(処理区病斑直径(mm)/無処理区病斑直
径(mm))〕×100 その結果、以下の化合物が防除価100を示した。 本発明化合物 No1、 No2、 No3、 No4、 No
6、 No9、 No11、No12、No21、No22、No9
5、No96、No111 、No131 、No167 、No168 、No169
、No170 、No171 、No172 、No173 、No174 、No175
、No176 、No177 、No178 、No180 、No181 、No182
、No183 、No185 、No186 、No188 、No189 、No190
、No191 、No263 、No264 、No265 、No266 、No276
、No277 、No278
Test Example 1 Gray mold control effect test A 1 to 2 leaf stage cucumber (cultivar: Sagamihanjiro) grown in a pot with a diameter of 7 cm was diluted with water to give 5
The chemical solution adjusted to 00 ppm was sprayed with 20 ml per pot using a spray gun. The next day, the leaves were cut from the cucumber sprayed with the drug solution and placed in a vat lined with water soaked paper. Add to this the Botrytis ciner
ea) spore suspension (1.0% glucose, 2.5% yeast extract, 150 × 40 / field) was spray-inoculated. After inoculation, the vat was covered with vinyl and placed in a thermostatic chamber at a temperature of 18 ° C. for 5 days. The diameter of the lesion formed was measured, and the control value was calculated according to the following formula. Control value = [1- (treatment group lesion diameter (mm) / untreated group lesion diameter (mm))] × 100 As a result, the following compounds showed a control value of 100. Inventive compound No1, No2, No3, No4, No
6, No9, No11, No12, No21, No22, No9
5, No96, No111, No131, No167, No168, No169
, No170, No171, No172, No173, No174, No175
, No176, No177, No178, No180, No181, No182
, No183, No185, No186, No188, No189, No190
, No191, No263, No264, No265, No266, No276
, No277, No278

【0109】試験例2 イネ紋枯病防除効果試験 直径5cmのポットで育成した3〜4葉期のイネ(品種:
日本晴)に、本発明化合物乳剤を水で希釈して500pp
m に調製した薬液を5ml 株元潅注した直後、同一ポット
にポット当たり15 ml 散布した。処理3日後に紋枯病
(Rhizoctonia solani)汚染籾穀を株元に置き接種し
た。その後ポットを、温度28℃、湿度95%以上の接
種箱に置き、接種5日後に形成された病斑の地極よりの
高さを測定し下記の式に従い防除価を算出した。 防除価=〔1−(処理区病斑高/無処理区病斑高)〕×
100 その結果以下の化合物が防除価100を示した。 本発明化合物 No1、 No2、 No3、 No6、 No
7、 No9、 No11、No12、No17、No21、No2
2、No95、No96、No99、No100 、No104 、No105
、No111 、No115 、No167 、No168 、No169 、No170
、No171 、No172 、No173 、No174 、No175 、No176
、No178 、No179 、No180 、No181 、No182 、No183
、No184 、No185 、No186 、No187 、No189 、No190
、No191 、No263 、No275 、No276 、No277 、No278
Test Example 2 Rice Stripe Blight Control Effect Test 3 to 4 leaf stage rice cultivated in a pot with a diameter of 5 cm (variety:
Nihonbare), the compound emulsion of the present invention was diluted with water to 500 pp
Immediately after 5 ml of the stock solution was irrigated with the drug solution prepared to m, 15 ml per pot was sprayed in the same pot. Three days after the treatment, rice grain contaminated with Rhizoctonia solani was placed at the base of the strain and inoculated. Then, the pot was placed in an inoculation box having a temperature of 28 ° C. and a humidity of 95% or more, and the height of the lesion formed 5 days after the inoculation above the ground pole was measured, and the control value was calculated according to the following formula. Control value = [1- (highly treated lesions / highly untreated lesions)] x
100 As a result, the following compounds showed a control value of 100. Inventive compound No1, No2, No3, No6, No
7, No9, No11, No12, No17, No21, No2
2, No95, No96, No99, No100, No104, No105
, No111, No115, No167, No168, No169, No170
, No171, No172, No173, No174, No175, No176
, No178, No179, No180, No181, No182, No183
, No184, No185, No186, No187, No189, No190
, No191, No263, No275, No276, No277, No278

【0110】[0110]

【発明の効果】本発明化合物は、新規な化合物であり、
優れた農園芸用殺菌作用を示し、有用作物に対する薬害
も認められないため、農園芸用殺菌剤として有用であ
る。
The compound of the present invention is a novel compound,
It has an excellent bactericidal action for agricultural and horticultural use, and has no phytotoxicity against useful crops.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.5 識別記号 庁内整理番号 FI 技術表示箇所 A01N 43/707 8930−4H 43/78 D 8930−4H C07D 401/06 8829−4C 401/12 231 8829−4C 403/06 8829−4C 417/06 9051−4C 417/12 231 9051−4C (72)発明者 廣原 洋司 千葉県船橋市坪井町722番地1 日産化学 工業株式会社中央研究所内 (72)発明者 三田 猛志 千葉県船橋市坪井町722番地1 日産化学 工業株式会社中央研究所内 (72)発明者 鈴木 秀雄 千葉県船橋市坪井町722番地1 日産化学 工業株式会社中央研究所内 (72)発明者 古里 孝 埼玉県南埼玉郡白岡町大字白岡1470 日産 化学工業株式会社生物科学研究所内 (72)発明者 大宅 博司 埼玉県南埼玉郡白岡町大字白岡1470 日産 化学工業株式会社生物科学研究所内 (72)発明者 中山 雅人 埼玉県南埼玉郡白岡町大字白岡1470 日産 化学工業株式会社生物科学研究所内 (72)発明者 花上 雅美 埼玉県南埼玉郡白岡町大字白岡1470 日産 化学工業株式会社生物科学研究所内 (72)発明者 豊田 竜太郎 埼玉県南埼玉郡白岡町大字白岡1470 日産 化学工業株式会社生物科学研究所内 (72)発明者 伊藤 忠 埼玉県南埼玉郡白岡町大字白岡1470 日産 化学工業株式会社生物科学研究所内─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 5 Identification code Internal reference number FI Technical display location A01N 43/707 8930-4H 43/78 D 8930-4H C07D 401/06 8829-4C 401/12 231 8829-4C 403/06 8829-4C 417/06 9051-4C 417/12 231 9051-4C (72) Inventor Hiroshi Hirohara 1 722, Tsuboicho, Funabashi, Chiba Prefecture Nissan Chemical Industry Co., Ltd. Central Research Laboratory (72) Invention Takeshi Mita 1 722, Tsuboi-cho, Funabashi, Chiba Prefecture, Central Research Laboratory, Nissan Chemical Industries, Ltd. (72) Inventor, Hideo Suzuki 1, 722, Tsuboi-cho, Funabashi City, Chiba Prefecture, Central Research Laboratory, Nissan Chemical Industries, Ltd. (72) Inventor, Furusato Takashi 1470 Shiraoka, Shiraoka-cho, Minami-Saitama-gun, Saitama Prefectural Institute of Biological Sciences, Nissan Chemical Industry Co., Ltd. NISSAN CHEMICAL INDUSTRIES, LTD.Biological Sciences Research Institute (72) Inventor Masato Nakayama 1470 Shiraoka, Shiraoka-cho, Minamisaitama-gun, Saitama NISSAN CHEMICAL INDUSTRIES, LTD. 1470 NISSAN CHEMICAL INDUSTRIAL CO., LTD.Biological Sciences Research Institute (72) Inventor Ryutaro Toyota Shiraoka, Shirooka-cho, Minami Saitama-gun, Saitama 1470 NISSAN CHEMICAL INDUSTRIES CO., LTD. 1470 Nissan Chemical Industries, Ltd.

Claims (8)

【特許請求の範囲】[Claims] 【請求項1】 式〔1〕: 【化1】 〔上記式中、R1は、ハロゲン原子、アルキル基、アルコ
キシ基、アルキルチオ基またはハロアルキル基を表し、
R2は、アルキル基またはハロアルキル基を表し、Xは、
-N(R3)- 、-CO-または-C(R4)(R5)- を表し、R3は、水素
原子、アルキル基、ハロアルキル基、アルケニル基、ア
ルキニル基、-COR6 または-SO2R7を表し、R4およびR
5は、それぞれ独立に水素原子、ハロゲン原子、アルキ
ル基、ハロアルキル基、アルケニル基、アルキニル基ま
たは-OR8を表し、R8は、水素原子、アルキル基、ハロア
ルキル基、アルケニル基、アルキニル基、アルコキシア
ルキル基、シアノアルキル基、アルキルカルボニルアル
キル基、アルコキシカルボニルアルキル基、無置換もし
くは置換基を有するフェニルアルキル基、-COR6 または
-SO2R7を表し、R6は、水素原子、アルキル基、ハロアル
キル基、無置換もしくは置換基を有するフェニル基、無
置換もしくは置換基を有するフェニルアルキル基、アル
コキシ基または-N(R9)(R10) を表し、R7は、アルキル
基、ハロアルキル基、無置換もしくは置換基を有するフ
ェニル基または-N(R9)(R10) を表し、R9およびR10 は、
それぞれ独立に水素原子、アルキル基または無置換もし
くは置換基を有するフェニル基を表し、Yは、酸素原
子、-S- 、-SO-、または -SO2-を表し、Aは、無置換も
しくは置換基を有するフェニル基を表し、Bは、無置換
もしくは置換基を有する複素環基を表す。但し、R1が、
アルキル基で、Xが、-N(R3)- で、Bが、無置換の2−
ピリジル基、無置換の2−ピリミジル基または無置換の
2−ピラジル基の場合を除く。〕で表される置換ピラゾ
ール誘導体またはその塩。
1. A formula [1]: [In the above formula, R 1 represents a halogen atom, an alkyl group, an alkoxy group, an alkylthio group or a haloalkyl group,
R 2 represents an alkyl group or a haloalkyl group, and X is
-N (R 3 )-, -CO- or -C (R 4 ) (R 5 )-represents, R 3 represents a hydrogen atom, an alkyl group, a haloalkyl group, an alkenyl group, an alkynyl group, -COR 6 or- Represents SO 2 R 7 , R 4 and R
5 independently represent a hydrogen atom, a halogen atom, an alkyl group, a haloalkyl group, an alkenyl group, an alkynyl group or -OR 8 , and R 8 represents a hydrogen atom, an alkyl group, a haloalkyl group, an alkenyl group, an alkynyl group, or an alkoxy group. Alkyl group, cyanoalkyl group, alkylcarbonylalkyl group, alkoxycarbonylalkyl group, unsubstituted or substituted phenylalkyl group, -COR 6 or
Represents -SO 2 R 7 , R 6 represents a hydrogen atom, an alkyl group, a haloalkyl group, an unsubstituted or substituted phenyl group, an unsubstituted or substituted phenylalkyl group, an alkoxy group or -N (R 9 ) (R 10 ), R 7 represents an alkyl group, a haloalkyl group, an unsubstituted or substituted phenyl group or —N (R 9 ) (R 10 ), and R 9 and R 10 represent
Each independently represents a hydrogen atom, an alkyl group or an unsubstituted or substituted phenyl group, Y represents an oxygen atom, —S—, —SO—, or —SO 2 —, and A is unsubstituted or substituted. Represents a phenyl group having a group, and B represents an unsubstituted or substituted heterocyclic group having a substituent. However, R 1 is
In the alkyl group, X is —N (R 3 ) — and B is an unsubstituted 2-
Except for a pyridyl group, an unsubstituted 2-pyrimidyl group or an unsubstituted 2-pyrazyl group. ] The substituted pyrazole derivative represented by these, or its salt.
【請求項2】 Aが、ハロゲン原子、アルキル基および
ハロアルキル基から選ばれた置換基の一種以上を有する
フェニル基である請求項1記載の置換ピラゾール誘導
体。
2. The substituted pyrazole derivative according to claim 1, wherein A is a phenyl group having at least one substituent selected from a halogen atom, an alkyl group and a haloalkyl group.
【請求項3】 Xが、-N(R3)- である請求項2記載の置
換ピラゾール誘導体
3. The substituted pyrazole derivative according to claim 2, wherein X is —N (R 3 ) —.
【請求項4】 Yが、-S- である請求項3記載の置換ピ
ラゾール誘導体。
4. The substituted pyrazole derivative according to claim 3, wherein Y is —S—.
【請求項5】 R1が、低級アルキル基またはハロゲン原
子であり、R2が、低級アルキル基である請求項4記載の
置換ピラゾール誘導体。
5. The substituted pyrazole derivative according to claim 4, wherein R 1 is a lower alkyl group or a halogen atom, and R 2 is a lower alkyl group.
【請求項6】 Bが、無置換もしくは置換基を有するピ
リジル基または無置換もしくは置換基を有するピリミジ
ル基である請求項5記載の置換ピラゾール誘導体。
6. The substituted pyrazole derivative according to claim 5, wherein B is an unsubstituted or substituted pyridyl group or an unsubstituted or substituted pyrimidyl group.
【請求項7】 R1が、ハロゲン原子である請求項6記載
の置換ピラゾール誘導体。
7. The substituted pyrazole derivative according to claim 6, wherein R 1 is a halogen atom.
【請求項8】 請求項1記載の置換ピラゾール誘導体の
1種または2種以上を有効成分として含有する農園芸用
殺菌剤。
8. A fungicide for agricultural and horticultural use containing one or more of the substituted pyrazole derivatives according to claim 1 as active ingredients.
JP9806093A 1992-05-07 1993-04-23 Substituted pyrazole derivative and germicide for agriculture and horticulture Pending JPH0665237A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9806093A JPH0665237A (en) 1992-05-07 1993-04-23 Substituted pyrazole derivative and germicide for agriculture and horticulture

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11500092 1992-05-07
JP4-115000 1992-05-07
JP9806093A JPH0665237A (en) 1992-05-07 1993-04-23 Substituted pyrazole derivative and germicide for agriculture and horticulture

Publications (1)

Publication Number Publication Date
JPH0665237A true JPH0665237A (en) 1994-03-08

Family

ID=26439271

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9806093A Pending JPH0665237A (en) 1992-05-07 1993-04-23 Substituted pyrazole derivative and germicide for agriculture and horticulture

Country Status (1)

Country Link
JP (1) JPH0665237A (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6664247B2 (en) * 2000-12-21 2003-12-16 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7141585B2 (en) 2000-07-07 2006-11-28 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7491730B2 (en) 2002-08-02 2009-02-17 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of GSK-3
US7528142B2 (en) 2005-11-03 2009-05-05 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
US7557106B2 (en) 2002-06-20 2009-07-07 Vertex Pharmaceuticals Incorporated Substituted pyrimidines useful as protein kinase inhibitors
US7563787B2 (en) 2005-09-30 2009-07-21 Miikana Therapeutics, Inc. Substituted pyrazole compounds
US7737151B2 (en) 2005-08-18 2010-06-15 Vertex Pharmaceuticals Incorporated Pyrazine kinase inhibitors
US8153630B2 (en) 2004-11-17 2012-04-10 Miikana Therapeutics, Inc. Kinase inhibitors
US8268811B2 (en) 2007-05-02 2012-09-18 Vertex Pharmaceuticals Inc. Thiazoles and pyrazoles useful as kinase inhibitors
US8541025B2 (en) 2008-09-03 2013-09-24 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same
JP2013536856A (en) * 2010-09-01 2013-09-26 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Bactericidal and fungicidal pyrazole
US8598361B2 (en) 2007-07-31 2013-12-03 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof
US8669081B2 (en) 2002-03-15 2014-03-11 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
CN107011326A (en) * 2009-03-03 2017-08-04 纳幕尔杜邦公司 Fungicidal pyrazoles compound

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141585B2 (en) 2000-07-07 2006-11-28 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
US7473691B2 (en) 2000-09-15 2009-01-06 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6664247B2 (en) * 2000-12-21 2003-12-16 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7427681B2 (en) 2000-12-21 2008-09-23 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US8697698B2 (en) 2000-12-21 2014-04-15 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US7531536B2 (en) 2000-12-21 2009-05-12 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US8669081B2 (en) 2002-03-15 2014-03-11 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of protein kinases
US8779127B2 (en) 2002-06-20 2014-07-15 Vertex Pharmaceuticals Incorporated Processes for preparing substituted pyrimidines
US7557106B2 (en) 2002-06-20 2009-07-07 Vertex Pharmaceuticals Incorporated Substituted pyrimidines useful as protein kinase inhibitors
US8268829B2 (en) 2002-06-20 2012-09-18 Vertex Pharmaceuticals Inc. Substituted pyrimidines useful as protein kinase inhibitors
US7872129B2 (en) 2002-08-02 2011-01-18 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of GSK-3
US7491730B2 (en) 2002-08-02 2009-02-17 Vertex Pharmaceuticals Incorporated Compositions useful as inhibitors of GSK-3
US8153630B2 (en) 2004-11-17 2012-04-10 Miikana Therapeutics, Inc. Kinase inhibitors
US7737151B2 (en) 2005-08-18 2010-06-15 Vertex Pharmaceuticals Incorporated Pyrazine kinase inhibitors
US7563787B2 (en) 2005-09-30 2009-07-21 Miikana Therapeutics, Inc. Substituted pyrazole compounds
US8114870B2 (en) 2005-09-30 2012-02-14 Miikana Therapeutics, Inc. Method of treating disease states using substituted pyrazole compounds
US7820685B2 (en) 2005-11-03 2010-10-26 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
US7528142B2 (en) 2005-11-03 2009-05-05 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
US7767672B2 (en) 2005-11-03 2010-08-03 Vertex Pharmaceuticals Incorporated Aminopyrimidines useful as kinase inhibitors
US8268811B2 (en) 2007-05-02 2012-09-18 Vertex Pharmaceuticals Inc. Thiazoles and pyrazoles useful as kinase inhibitors
US8598361B2 (en) 2007-07-31 2013-12-03 Vertex Pharmaceuticals Incorporated Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof
US8541025B2 (en) 2008-09-03 2013-09-24 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical formulations comprising the same
CN107011326A (en) * 2009-03-03 2017-08-04 纳幕尔杜邦公司 Fungicidal pyrazoles compound
CN107011326B (en) * 2009-03-03 2019-11-12 Fmc公司 Fungicidal pyrazoles compound
JP2013536856A (en) * 2010-09-01 2013-09-26 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー Bactericidal and fungicidal pyrazole

Similar Documents

Publication Publication Date Title
JPH0532662A (en) Substituted pyrazole derivative and agricultural and horticultural fungicide
JPH0665237A (en) Substituted pyrazole derivative and germicide for agriculture and horticulture
JP3726306B2 (en) Pyrazolecarboxylic acid derivatives and plant disease control agents
EP0627423A1 (en) Substituted pyrazole derivative and agrohorticultural bactericide
EP1072598B9 (en) Pyrazolinone derivatives
JP2000226374A (en) Pyrazolinone derivative
JPS6069067A (en) Phenylpropylazole, its production and plant blight controlling agent containing said compound as active component
JP2000159610A (en) Plant disease control agent for agriculture and horticulture and new isooxazole carboxylic acid derivative
JP4039707B2 (en) Substituted pyrazole derivatives, process for producing the same, and agricultural and horticultural fungicides containing the derivatives as active ingredients
JP3966933B2 (en) Substituted pyrazole derivatives, process for producing the same, and agricultural and horticultural fungicides containing the same as active ingredients
JPH0948766A (en) Triazolone derivative, its use and intermediate thereof
JPH05279339A (en) Substituted pyrazol derivative and agricultural and horticultural germicide
JP3966929B2 (en) Substituted pyrazole derivatives, process for producing the same, and agricultural and horticultural fungicides containing the same as active ingredients
JP2001019691A (en) Pyrazolebenzoxazine or pyrazolebenzothiazine compound and antifungal agent for agriculture and horticulture
JPH06220049A (en) Oxazolinone derivative and fungicide for agriculture and horticulture
JPH07309825A (en) Oxime ether derivative, its application and production intermediate therefor
JPH0827133A (en) Bicyclic compound, its use and intermediate for producing the same
JPH05345751A (en) Substituted anilide derivative and agricultural and horticultural germicide
JPH0812653A (en) Carboxylic oxime ester derivative and microbicidal agent for agricultural and horticultural purposes
JPH08301867A (en) Pyrazoline derivative, its use and intermediate therefor
JPH05194398A (en) Acrylic acid derivative, its production and vegetable disease-controlling agent containing the same compound as active component
JPH07330735A (en) Pyrazolyloxy acetic acid derivative, its use and intermediate for producing the same
JPH02131480A (en) Pyridylpyrimidine derivative and agricultural and horticultural germicide containing the same as active ingredient
JPH11228567A (en) Substituted thiophene derivative and plant disease-controlling agent containing the same as active ingredient
JPH09104676A (en) Triazolone derivative and its use